Malignant neoplasm of bladder

C3_BLADDER

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Cause of death: ICD-10 — C67 Cause of death: ICD-9 — 188 Cause of death: ICD-8 — 188 Cancer registry: Topography ICD-O-3 — C67 Cancer registry: Morphology ICD-O-3 — ANY Cancer registry: Behaviour codes — 3 2 out of 7 registries used, show all original rules.	3027
4. Check minimum number of events None	3027
5. Include endpoints None	3027
6. Filter based on genotype QC (FinnGen only)	2927

Control definitions (FinnGen only)

Control exclude: C3_CANCER, C3_CANCER_WIDE

Extra metadata

Level in the ICD hierarchy: 2
First used in FinnGen datafreeze: DF9

NAME	C3_BLADDER
CONTROL_EXCLUDE	C3_CANCER\|C3_CANCER_WIDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	C67
COD_ICD_9	188
COD_ICD_8	188
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO	C67
CANC_TOPO_EXCL
CANC_MORPH	ANY
CANC_MORPH_EXCL
CANC_BEHAV	3

Similar endpoints

↥

List of similar endpoints to Malignant neoplasm of bladder based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	2927	469	2458
Unadjusted period prevalence (%)	0.97	0.17	1.13
Median age at first event (years)	71.07	68.31	71.59

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
3027: Matched controls
30243

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

C44.31

ICD-10 Finland

Basocellular carcinoma of the skin on another or unspecified part of the face

69.1

322.6

176

Z08.0

ICD-10 Finland

Follow-up examination after surgery for malignant neoplasm

167.6

321.6

159

A04AA01

ATC

ondansetron; systemic, rectal

15.8

320.9

285

198

KCW02

NOMESCO Finland

Lavation of bladder for coagulated blood

17.9

316.3

262

159

Z51.5

ICD-10 Finland

Palliative care

7.9

311.8

468

685

KCD32

NOMESCO Finland

Cystoscopic destruction of tumour of bladder

132.1

307.7

561

JN4BD

NOMESCO Finland

Extensive body CT

8.7

307.7

522

705

KH1CD

NOMESCO Finland

Very extensive urinary tract ultrasound examination

43.8

307.7

290

C67.9

ICD-10 Finland

Malignant neoplasm: Bladder, unspecified

10879.5

307.7

1636

TJF80

NOMESCO Finland

Ostomy education

96.1

307.7

181

KCD02

NOMESCO Finland

Transurethral resection of bladder

1512.7

307.7

2262

KCC10

NOMESCO Finland

Cystoprostatectomy

+∞

307.7

473

JN4AD

NOMESCO Finland

Body CT examination

8.3

307.7

534

762

R31

ICD-10 Finland

Unspecified haematuria

12.1

307.7

1547

2396

A03FA01

ATC

metoclopramide; systemic, rectal

7.5

307.7

820

1424

8140/3-C61.9

ICD-O-3

Adenocarcinoma, NOS, of prostate gland

+∞

307.7

567

C67.2

ICD-10 Finland

Malignant neoplasm: Lateral wall of bladder

+∞

307.7

850

130

Kela drug reimbursment

Malignant tumour

+∞

307.7

721

C67.0

ICD-10 Finland

Malignant neoplasm: Trigone of bladder

+∞

307.7

334

KBJ10

NOMESCO Finland

Cutaneous ureteroenterostomy

+∞

307.7

496

KH1BT

NOMESCO Finland

Urinary tract cathetrisation with X-ray guidance

64.5

307.7

287

H02AB02

ATC

dexamethasone; systemic

41.3

307.7

467

133

N13.3

ICD-10 Finland

Other and unspecified hydronephrosis

24.0

307.7

344

161

KCB00

NOMESCO Finland

Biopsy of bladder

99.4

307.7

178

UKC05

NOMESCO Finland

Cystoscopy and bladder biopsy

84.5

307.7

454

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

6.8

307.7

595

1053

PJD54

NOMESCO Finland

Block dissection of iliac lymph nodes

3900.3

307.7

357

C61

ICD-10 Finland

Malignant neoplasm of prostate

903.8

307.7

586

ZX136

NOMESCO Finland

Intravesicalis

171.8

307.7

350

C67.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bladder

+∞

307.7

1968

UKC02

NOMESCO Finland

Cystoscopy

44.7

307.7

2615

3760

WF002

NOMESCO Finland

Radical radiotherapy

116.6

307.7

176

KCD05

NOMESCO Finland

Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)

730.1

307.7

805

D41.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Bladder

241.9

307.7

1174

8120/3-C67.9

ICD-O-3

Transitional cell carcinoma, NOS, of bladder, NOS

+∞

307.7

2261

KCW96

NOMESCO Finland

Other operations on bladder

44.7

304.2

181

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

142.3

297.5

149

A04AA02

ATC

granisetron; systemic, transdermal

630.8

294.3

287

KH1BD

NOMESCO Finland

Extensive urinary tract CT examination

31.1

272.1

179

J01MA02

ATC

ciprofloxacin; systemic

3.6

263.7

1779

8511

116

Kela drug reimbursment

Prostate cancer

+∞

262.3

248

KH1FT

NOMESCO Finland

Exchange of urinary catheter with radiological guidance

107.7

260.5

134

JN4CD

NOMESCO Finland

Very extensive body CT

15.0

258.0

234

168

KA1AE

NOMESCO Finland

Kidney ultrasound examination

11.8

251.9

266

245

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

121.3

251.8

128

WX302

NOMESCO Finland

Thoracal epidural anesthesy

12.8

247.9

248

210

TKW99

NOMESCO Finland

Other minor surgical procedure in urology

33.0

243.5

157

WC305

NOMESCO Finland

Simple therapy of local tumor recidive with biomodifiers

+∞

243.0

230

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

834.7

238.9

232

8130/3-C67.9

ICD-O-3

Papillary urothelial carcinoma of bladder, NOS

+∞

231.2

219

KBV02

NOMESCO Finland

Cystoscopic insertion of stent into ureter

12.1

230.8

238

211

J01EA01

ATC

trimethoprim; systemic

3.6

229.3

1040

3802

XX3DW

NOMESCO Finland

Time consuming IT work

7.1

220.0

353

550

308

Kela drug reimbursment

Alprostadil, sildenafil and combination product containing aviptadil and phentolamine

86.0

219.5

116

1888X

ICD-9 Finland

Malignant neoplasm of bladder, Other specified sites of bladder

+∞

218.3

207

KA3EB

NOMESCO Finland

Antegrade pyelography

57.7

216.8

122

WX408

NOMESCO Finland

General anesthesy, balanced

3.6

213.5

966

3504

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

7.3

210.3

328

495

TKC20

NOMESCO Finland

Catheterisation of bladder

4.5

208.5

585

1513

C67

ICD-10 Finland

Malignant neoplasm of bladder

+∞

206.6

196

U76

ICPC

Malignant neoplasm of bladder

1978.1

204.3

196

7321

FHL

TU biopsy, coagulation or laser

46.2

203.6

120

WF049

NOMESCO Finland

Radiotherapy of metastasis

1955.6

202.2

194

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

3.6

200.2

850

2944

U06

ICPC

Haematuria

8.2

199.0

277

367

B01AB10

ATC

tinzaparin; parenteral

5.4

192.6

415

859

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

+∞

185.3

176

XKD00

NOMESCO Finland

Uroflowmetry

3.2

182.4

1011

4097

ZXC20

NOMESCO Finland

Use of chemical agents

14.0

177.5

166

125

WB121

NOMESCO Finland

Demanding neoadjuvant cytostatic therapy

+∞

176.8

168

L02AE02

ATC

leuprorelin; implant, parenteral

892.4

173.7

169

C67.1

ICD-10 Finland

Malignant neoplasm: Dome of bladder

+∞

173.6

165

L03AA02

ATC

filgrastim; parenteral

61.9

172.7

N02AA05

ATC

oxycodone; systemic

3.4

169.8

776

2786

C67.4

ICD-10 Finland

Malignant neoplasm: Posterior wall of bladder

+∞

169.3

161

WZC00

NOMESCO Finland

Treatment plan or consultation

3.1

165.6

945

3864

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

3.2

161.2

811

3076

8090/3-C44.9

ICD-O-3

Basal cell carcinoma, NOS, of skin, NOS

+∞

157.6

150

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

3.3

157.5

756

2783

B02AA02

ATC

tranexamic acid; systemic

4.3

152.9

435

1124

7323

FHL

Electrosection of TU bladder wall change

396.6

152.5

152

WX320

NOMESCO Finland

Spinalanesthesy

2.9

150.2

993

4369

A04AD12

ATC

aprepitant; systemic

+∞

149.2

142

KA1FN

NOMESCO Finland

Isotope renography

33.8

144.1

UKB02

NOMESCO Finland

Retrograde ureteroscopy

13.8

143.0

134

101

WF004

NOMESCO Finland

Palliative radiotherapy

1458.0

142.8

138

KH1YT

NOMESCO Finland

Percutaneous implantation of endoprothesis with radiological guidance

71.7

141.8

KBJ60

NOMESCO Finland

Anastomosis of ureter to urethra with interposition of ileum

+∞

133.3

127

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

6.1

132.2

242

427

WC105

NOMESCO Finland

Simple cytostatic therapy of local tumor recidive

438.7

127.8

127

KCC30

NOMESCO Finland

Cystectomy with excision of female internal genital organs

+∞

122.7

117

A04AA55

ATC

palonosetron, combinations; systemic

+∞

122.7

117

L02BB03

ATC

bicalutamide; oral

+∞

121.6

116

J01MA12

ATC

levofloxacin; systemic

2.7

121.1

831

3669

JN3AD

NOMESCO Finland

Abdominal CT examination

3.6

120.8

455

1422

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

1214.5

120.7

117

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

6.0

119.9

219

385

KH1AD

NOMESCO Finland

CT of urinary organs

6.1

117.5

214

375

8120/3-C67.2

ICD-O-3

Transitional cell carcinoma, NOS, of lateral wall of bladder

+∞

115.3

110

KC1GB

NOMESCO Finland

Cystography with X-ray

156.0

114.0

120

WZC30

NOMESCO Finland

Teaching

3.4

113.2

477

1598

KDV10

NOMESCO Finland

Internal urethrotomy

7.4

113.1

169

241

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

9.1

108.7

135

154

UKA02

NOMESCO Finland

Retrograde ureteronephroscopy

32.5

108.4

KBV12

NOMESCO Finland

Transluminal endoscopic removal of stent from ureter

10.6

107.6

119

116

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

6.2

107.0

189

321

JEA00

NOMESCO Finland

Appendectomy

4.8

105.7

250

553

WX402

NOMESCO Finland

General anaesthesia

3.1

105.0

528

1959

8090/3-C44.3

ICD-O-3

Basal cell carcinoma, NOS, of skin of other and unspecified parts of face

+∞

104.8

100

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

519.6

102.2

101

B01AB05

ATC

enoxaparin; parenteral

2.4

99.9

994

5159

YL1BD

NOMESCO Finland

Extensive CT examination of pelvis for dose design of radiotherapy

+∞

99.5

KBV15

NOMESCO Finland

Cystoscopic change of ureteral stent

29.3

98.9

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

5.6

98.8

195

368

SPAT1125

SPAT

Stoma care and guidance

7.7

97.3

139

188

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

+∞

95.3

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

3.0

94.6

494

1865

YL1AD

NOMESCO Finland

CT examination of pelvis for dose design of radiotherapy

935.8

93.4

TPH07

NOMESCO Finland

Cathetrisation of artery

3.0

93.0

474

1764

N30.0

ICD-10 Finland

Acute cystitis

2.9

91.8

501

1935

ZXC15

NOMESCO Finland

Use of photodynamic technique

12.5

91.8

C44.51

ICD-10 Finland

Basocellular carcinoma of the skin on the torso

25.7

90.2

NK6AN

NOMESCO Finland

Total body bone isotope imaging

42.2

89.6

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.8

89.6

516

2050

KCD30

NOMESCO Finland

Destruction of tumour of bladder

+∞

89.0

1530

FHL

Urethrocystoscopy

5.1

88.2

193

399

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

+∞

87.9

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

6.6

87.5

143

224

L03AA13

ATC

pegfilgrastim; parenteral

303.8

87.2

JN3BD

NOMESCO Finland

Extensive abdominal CT

3.2

83.9

365

1236

C79.5

ICD-10 Finland

Secondary malignant neoplasm of bone and bone marrow

+∞

83.7

KBV00

NOMESCO Finland

Insertion of stent into ureter

21.1

82.2

Y77

ICPC

Malignant neoplasm prostate

215.7

81.7

C66

ICD-10 Finland

Malignant neoplasm of ureter

+∞

80.5

WD325

NOMESCO Finland

Demanding therapy of methastized malignancy with biomodifiers

210.4

79.6

UKD02

NOMESCO Finland

Urethroscopy

15.2

79.4

A06AH03

ATC

naloxegol; oral

17.0

78.1

R33

ICD-10 Finland

Retention of urine

2.5

77.9

564

2500

D30.3

ICD-10 Finland

Benign neoplasm: Bladder

35.5

77.7

R82.8

ICD-10 Finland

Abnormal findings on cytological and histological examination of urine

36.7

75.2

PJD44

NOMESCO Finland

Excision of iliac lymph nodes

745.7

74.5

D41.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Kidney

7.3

73.8

109

153

KE1AT

NOMESCO Finland

Biopsy of prostata with ultrasoudnguidance

4.7

72.0

172

382

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.5

71.4

529

2363

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

360.2

70.9

G04BE03

ATC

sildenafil; oral

16.7

70.2

D41.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Renal pelvis

98.7

70.2

C65

ICD-10 Finland

Malignant neoplasm of renal pelvis

+∞

70.0

C67.3

ICD-10 Finland

Malignant neoplasm: Anterior wall of bladder

+∞

70.0

Z3231

NOMESCO Finland

Registered nurse

2.1

70.0

882

4918

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.9

68.2

1475

9929

U99

ICPC

Urinary disease other

9.5

68.1

ZX090

NOMESCO Finland

Other technic of radiotherapy

124.5

68.1

KCC20

NOMESCO Finland

Cystoprostatourethrectomy

+∞

67.9

C67.5

ICD-10 Finland

Malignant neoplasm: Bladder neck

+∞

67.9

WW500

NOMESCO Finland

Blood transfusion

5.3

67.2

139

273

WX882

NOMESCO Finland

High dependency care

4.7

65.4

157

350

KCW98

NOMESCO Finland

Other transluminal endoscopic operation on bladder

32.7

65.0

C64.88

ICD-10 Finland

Other malignant neoplasm of kidney, except renal pelvis

640.9

64.1

8000/3-C67.9

ICD-O-3

Neoplasm, malignant of bladder, NOS

+∞

63.7

ZXE00

NOMESCO Finland

One hour or less

1.9

62.6

1109

6929

1889X

ICD-9 Finland

Malignant neoplasm of bladder, Bladder, part unspecified

+∞

61.6

Z51.1

ICD-10 Finland

Chemotherapy session for neoplasm

319.0

61.6

J01CA08

ATC

pivmecillinam; oral

2.1

60.6

698

3731

KDV12

NOMESCO Finland

Urethroscopic internal urethrotomy

7.2

60.6

130

D09.0

ICD-10 Finland

Carcinoma in situ: Bladder

313.6

60.5

WF003

NOMESCO Finland

Adjuvant radiotherapy

302.7

58.5

ZXD10

NOMESCO Finland

Scheduled procedure

1.9

57.8

1120

7163

ZXE10

NOMESCO Finland

More than one and less than three hours

1.9

55.9

1034

6500

8130/2-C67.9

ICD-O-3

Papillary urothelial carcinoma, non-invasive of bladder, NOS

557.6

55.7

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

5.9

53.8

171

TPH04

NOMESCO Finland

Cathetrisation of vein

2.0

53.5

685

3789

KAC20

NOMESCO Finland

Nephroureterectomy

+∞

53.3

ZXE30

NOMESCO Finland

More than five and less than seven hours

3.5

53.0

195

591

WX224

NOMESCO Finland

Blockade of obturius nerve

526.5

52.6

YX9AD

NOMESCO Finland

Other CT eamination for dose design of radiotherapy

95.0

51.0

PJA12

NOMESCO Finland

Sentinel node biopsy

259.4

50.2

J01DB01

ATC

cefalexin; oral

1.9

49.9

2182

17555

N13.1

ICD-10 Finland

Hydronephrosis with ureteral stricture, not elsewhere classified

17.3

49.7

KCV22

NOMESCO Finland

Transluminal endoscopic evacuation of blood clots from bladder

19.2

48.4

XKD10

NOMESCO Finland

Transurethral ultrasonography

+∞

48.0

N30.9

ICD-10 Finland

Cystitis, unspecified

3.0

47.2

226

802

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

+∞

47.0

L01BC06

ATC

capecitabine; oral

+∞

47.0

Z08.7

ICD-10 Finland

Follow-up examination after combined treatment for malignant neoplasm

127.0

46.9

KCC00

NOMESCO Finland

Cystectomy

464.4

46.4

A79

ICPC

Malignancy NOS

75.6

46.1

ZZR00

NOMESCO Finland

Flap of skin

10.1

46.0

N02BE01

ATC

paracetamol; systemic, rectal

1.9

46.0

2409

20201

4CX01, ,

NOMESCO Finland

+∞

45.9

18899

ICD-8 Finland

Malignant neoplasm of bladder

+∞

45.9

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

13.6

45.9

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

7.0

45.8

102

GD1CT

NOMESCO Finland

Biopsy of the lung with CT guidance

12.4

44.4

C34.1

ICD-10 Finland

Malignant neoplasm: Upper lobe, bronchus or lung

+∞

43.8

KED22

NOMESCO Finland

Transurethral resection of prostate

2.2

43.4

405

1972

N12

ICD-10 Finland

Tubulo-interstitial nephritis, not specified as acute or chronic

4.3

43.2

112

265

ZX070

NOMESCO Finland

Intensity modified radiotherapy

223.0

43.0

TKE00

NOMESCO Finland

Needle biopsy of prostate

3.2

42.6

180

594

KBV10

NOMESCO Finland

Removal of stent from ureter

10.1

42.5

C68.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of urinary organs

+∞

41.7

U28

ICPC

Limited function/disability (U)

5.2

41.5

169

115

Kela drug reimbursment

Breast cancer

+∞

40.7

KWA00

NOMESCO Finland

Repair of wound dehiscence in urological surgery

+∞

39.7

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

3.2

39.1

164

538

C20.91

ICD-10 Finland

Malignant tumor of the rectum invasive carcinoma

+∞

38.6

8120/3-C67.4

ICD-O-3

Transitional cell carcinoma, NOS, of posterior wall of bladder

+∞

38.6

SPAT1262

SPAT

Handing over of treatment supplies

1.9

37.6

612

3622

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

3.3

37.2

141

435

UKC12

NOMESCO Finland

Retrograde endoscopy of cutaneous cystoenterostomy

+∞

36.5

KBJ80

NOMESCO Finland

Operation for malfunction of urinary diversion

+∞

36.5

PJD64

NOMESCO Finland

Laparoscopic dissection of iliac lymph nodes

+∞

36.5

8090/3-C44.5

ICD-O-3

Basal cell carcinoma, NOS, of skin of trunk

+∞

36.5

ZXC96

NOMESCO Finland

Robot assisted procedure

10.1

36.2

ZX120

NOMESCO Finland

Intravenous

2.4

36.1

256

1105

N13.9

ICD-10 Finland

Obstructive and reflux uropathy, unspecified

9.7

35.9

C44.41

ICD-10 Finland

Basocellular carcinoma of the skin of the scalp and neck

98.7

35.8

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

2.1

35.6

351

1740

U77

ICPC

Malignant neopl urinary tract other

+∞

35.5

N02AX02

ATC

tramadol; systemic, rectal

1.6

35.4

1191

8595

U07

ICPC

Urine symptom/complaint other

2.5

35.1

240

1018

G04BD08

ATC

solifenacin; oral

2.5

35.1

244

1043

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.7

35.0

199

772

D70.82

ICD-10 Finland

Drug-induced neutropenia

14.0

34.8

R74.8

ICD-10 Finland

Abnormal levels of other serum enzymes

2.9

34.3

162

569

JAH00

NOMESCO Finland

Laparotomy

3.7

34.1

108

296

K56.5

ICD-10 Finland

Intestinal adhesions [bands] with obstruction

4.7

33.6

173

C34.12

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma

+∞

33.4

8140/3-C20.9

ICD-O-3

Adenocarcinoma, NOS, of rectum, NOS

+∞

33.4

8120/3-C67.8

ICD-O-3

Transitional cell carcinoma, NOS, of overlapping lesion of bladder

+∞

33.4

U70

ICPC

Pyelonephritis/pyelitis

5.3

33.1

129

YG1BD

NOMESCO Finland

Extensive CT examination of thorax for dose design of radiotherapy

330.4

32.9

ZXD05

NOMESCO Finland

Urgent procedure

1.6

32.3

914

6283

C77.2

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes

+∞

32.3

C20.90

ICD-10 Finland

Malignant tumor of the rectum without histology

320.1

31.9

Z51.0

ICD-10 Finland

Radiotherapy session

320.1

31.9

L02AE03

ATC

goserelin; implant

166.6

31.7

C44.32

ICD-10 Finland

Spinocellular carcinoma of the skin on another or unspecified part of the face

48.0

31.6

N13.0

ICD-10 Finland

Hydronephrosis with ureteropelvic junction obstruction

9.6

31.5

U29

ICPC

Urinary symptom/complaint other

3.2

31.3

124

393

C34.3

ICD-10 Finland

Malignant neoplasm: Lower lobe, bronchus or lung

+∞

31.3

YJ2VG

NOMESCO Finland

MRI examination of pelvis with high intensity magnet for dose design of radiotherapy

+∞

31.3

G04CA02

ATC

tamsulosin; oral

1.6

31.2

1291

9703

C44.30

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face without histology

111.1

30.7

Z93.6

ICD-10 Finland

Other artificial openings of urinary tract status

111.1

30.7

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

5.5

30.5

109

GD1AD

NOMESCO Finland

Thorax CT examination

2.7

30.5

174

676

G04BD12

ATC

mirabegron; oral

2.0

30.3

371

1987

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

+∞

30.2

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

3.1

30.1

130

434

R4110

NOMESCO Finland

Physiotherapy

1.7

30.1

699

4552

KEC00

NOMESCO Finland

Retropubic radical prostatectomy

305.1

29.8

J01MA01

ATC

ofloxacin; systemic

2.1

29.6

322

1653

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

3.7

29.5

259

166

Kela drug reimbursment

Dalteparin and tinzaparin (treatment for more than 6 months)

+∞

29.2

UKB12

NOMESCO Finland

Retrograde endoscopy of cutaneous ureteroenterostomy

+∞

29.2

ZX080

NOMESCO Finland

Image guided radiotherapy

+∞

29.2

R50.9

ICD-10 Finland

Fever, unspecified

1.9

28.7

424

2415

Z03.1

ICD-10 Finland

Observation for suspected malignant neoplasm

4.6

28.7

154

8120/2-C67.9

ICD-O-3

Urothelial carcinoma in situ of bladder, NOS

151.3

28.7

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.1

28.5

285

1416

JN2CG

NOMESCO Finland

Extensive MRI examination of lower part of abdoment with high intensity magnet

8.3

28.2

U13

ICPC

Bladder symptom/complaint other

3.4

28.2

101

301

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

55.5

28.1

QBA25

NOMESCO Finland

Destruction of lesion of skin of trunk

6.9

28.0

C44.21

ICD-10 Finland

Basocellular carcinoma of the skin of the outer ear and the outer ear canal

146.2

27.7

Z93

ICD-10 Finland

Artificial opening status

53.8

27.2

8070/3-C44.9

ICD-O-3

Squamous cell carcinoma, NOS, of skin, NOS

+∞

27.1

C67.6

ICD-10 Finland

Malignant neoplasm: Ureteric orifice

+∞

27.1

C25.9

ICD-10 Finland

Malignant neoplasm: Pancreas, unspecified

+∞

27.1

C67.7

ICD-10 Finland

Malignant neoplasm: Urachus

+∞

27.1

D41.2

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Ureter

+∞

27.1

SPAT1167

SPAT

Insertion of urinary catheter

2.5

26.8

173

713

8500/3-C50.9

ICD-O-3

Infiltrating duct carcinoma, NOS, of breast, NOS

273.2

26.7

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

3.9

26.7

202

C77.5

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intrapelvic lymph nodes

+∞

26.1

8120/3-C67.5

ICD-O-3

Transitional cell carcinoma, NOS, of bladder neck

+∞

26.1

8120/3-C67.6

ICD-O-3

Transitional cell carcinoma, NOS, of ureteric orifice

+∞

26.1

C50.41

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor

+∞

26.1

C79.30

ICD-10 Finland

Secondary malignant tumor of the cerebrum

+∞

26.1

C78.6

ICD-10 Finland

Secondary malignant neoplasm of retroperitoneum and peritoneum

+∞

26.1

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.6

25.8

249

J01MA06

ATC

norfloxacin; oral

1.9

25.5

347

1921

JFF23

NOMESCO Finland

Transversostomy

10.4

25.3

U71

ICPC

Cystitis/urinary infection other

2.8

25.3

129

473

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

2.7

25.0

137

521

8310/3-C64.9

ICD-O-3

Clear cell adenocarcinoma, NOS, of kidney, NOS

+∞

25.0

XZZ00

NOMESCO Finland

Active surveillance of a diagnosed cancer

+∞

25.0

163

Kela drug reimbursment

Abiraterone and enzalutamide

+∞

25.0

C18.71

ICD-10 Finland

Malignant tumor of the sigmoid invasive carcinoma

+∞

25.0

8120/3-C67.1

ICD-O-3

Transitional cell carcinoma, NOS, of dome of bladder

+∞

25.0

8720/3-C44.5

ICD-O-3

Malignant melanoma, NOS, of skin of trunk

+∞

25.0

G04BE01

ATC

alprostadil; parenteral, urethral

3.1

24.7

107

358

KE3AT

NOMESCO Finland

Transrectal gold marker implantation in prostate under ultrasound guidance

252.0

24.7

A02BC02

ATC

pantoprazole; systemic

1.5

24.4

1724

14236

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

2.2

24.3

209

977

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.5

24.2

1128

8564

JFB30

NOMESCO Finland

Right hemicolectomy

6.9

24.2

C34.32

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma

+∞

24.0

GDC01

NOMESCO Finland

Thoracoscopic lobectomy of lung

+∞

24.0

3AX03, ,

NOMESCO Finland

+∞

24.0

L03AA14

ATC

lipegfilgrastim; parenteral

+∞

24.0

C34.11

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma

+∞

24.0

WD135

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

+∞

24.0

C25.0

ICD-10 Finland

Malignant neoplasm: Head of pancreas

+∞

24.0

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

3.8

23.9

200

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

2.6

23.7

146

589

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

2.8

23.6

122

450

U05

ICPC

Urination problems other

2.2

23.4

201

940

D37.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other digestive organs

4.3

23.0

139

C34.10

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung without histology

+∞

22.9

JAP00

NOMESCO Finland

Freeing of adhesions in the peritoneal cavity

7.4

22.9

Z2221

NOMESCO Finland

Medical doctor

1.6

22.7

637

4313

C34.90

ICD-10 Finland

Malignant tumor in unspecified location in bronchus and lung without histology

231.5

22.6

WX704

NOMESCO Finland

Intubation

2.2

22.5

186

856

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

2.5

22.5

143

586

ZXE40

NOMESCO Finland

More than seven and less than nine hours

3.4

22.3

239

KA3GB

NOMESCO Finland

Retrograde pyelography

35.3

22.0

C68.0

ICD-10 Finland

Malignant neoplasm: Urethra

+∞

21.9

8070/3-C44.3

ICD-O-3

Squamous cell carcinoma, NOS, of skin of other and unspecified parts of face

+∞

21.9

C77.8

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions

+∞

21.9

8140/3-C18.7

ICD-O-3

Adenocarcinoma, NOS, of sigmoid colon

+∞

21.9

UKC22

NOMESCO Finland

Urethroneocystoscopy

+∞

21.9

U14

ICPC

Kidney symptom/complaint

3.6

21.7

204

KBD00

NOMESCO Finland

Partial excision of ureter

221.3

21.6

A41.8

ICD-10 Finland

Other specified sepsis

3.2

21.6

274

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.8

21.3

344

2005

KH1CB

NOMESCO Finland

Urography with X-ray

26.6

21.3

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

5.7

21.1

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

2.1

20.9

199

969

TPX10

NOMESCO Finland

Implantation of vascular injection port

3.3

20.9

244

C43.52

ICD-10 Finland

Malignant melanoma on the torso: 'superficial spreading' type

+∞

20.8

C44.39

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face other or unspecified histology

+∞

20.8

C34.31

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung epidermoid carcinoma

+∞

20.8

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.8

20.8

306

1735

KAC10

NOMESCO Finland

Total nephrectomy with capsule

77.3

20.7

C22.0

ICD-10 Finland

Malignant neoplasm: Liver cell carcinoma

211.2

20.6

C20

ICD-10 Finland

Malignant neoplasm of rectum

110.7

20.6

KBH20

NOMESCO Finland

Replantation of ureter

41.9

20.4

TKC22

NOMESCO Finland

Catheterisation instruction

2.9

20.4

332

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.5

20.2

771

5573

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.0

19.9

222

1146

ZXE20

NOMESCO Finland

More than three and less than five hours

1.7

19.9

366

2216

KAC21

NOMESCO Finland

Percutaneous endoscopic nephroureterectomy

+∞

19.8

L02BB04

ATC

enzalutamide; oral

+∞

19.8

WC135

NOMESCO Finland

Very demanding cytostatic therapy of local tumor recidive

+∞

19.8

C18.21

ICD-10 Finland

Malignant tumor of the ascending colon invasive carcinoma

+∞

19.8

8312/3-C64.9

ICD-O-3

Renal cell carcinoma, NOS, of kidney, NOS

+∞

19.8

AA1BD

NOMESCO Finland

Extensive CT of head and brain

3.6

19.7

184

YX9BD

NOMESCO Finland

Other extensive CT eamination for dose design of radiotherapy

201.1

19.6

U79

ICPC

Neoplasm urinary tract unspecified

201.1

19.6

YG1AD

NOMESCO Finland

CT examination of thorax for dose design of radiotherapy

201.1

19.6

KH1RT

NOMESCO Finland

Urinary tract dilatatation with radiological guidance

201.1

19.6

QAA05

NOMESCO Finland

Incision for biopsy of skin of head or neck

4.0

19.6

139

JN6AD

NOMESCO Finland

CT of torso and neck

6.9

19.5

KH1DD

NOMESCO Finland

CT urography of urinary organs

21.7

19.5

L57.0

ICD-10 Finland

Actinic keratosis

1.9

19.2

243

1311

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.6

19.0

111

437

ZX112

NOMESCO Finland

Subcutaneous

5.7

19.0

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.6

18.8

569

3901

8090/3-C44.4

ICD-O-3

Basal cell carcinoma, NOS, of skin of scalp and neck

+∞

18.8

L01CA04

ATC

vinorelbine; systemic

+∞

18.8

KDC00

NOMESCO Finland

Urethrectomy

+∞

18.8

KEC01

NOMESCO Finland

Percutaneous endoscopic radical prostatectomy

+∞

18.8

8000/3-C34.9

ICD-O-3

Neoplasm, malignant of lung, NOS

+∞

18.8

8070/3-C34.9

ICD-O-3

Squamous cell carcinoma, NOS, of lung, NOS

+∞

18.8

8170/3-C22.0

ICD-O-3

Hepatocellular carcinoma, NOS, of liver

+∞

18.8

N17.9

ICD-10 Finland

Acute renal failure, unspecified

2.1

18.7

184

907

KCD10

NOMESCO Finland

Partial cystectomy

70.3

18.7

C44.61

ICD-10 Finland

Basocellular carcinoma of the skin of the upper extremity including the shoulder

28.0

18.7

WX110

NOMESCO Finland

Infiltration anesthesia

1.4

18.4

1454

11995

G03HA01

ATC

cyproterone; systemic

30.2

18.3

J01CA04

ATC

amoxicillin; systemic

1.4

18.3

1931

16738

N99.5

ICD-10 Finland

Malfunction of external stoma of urinary tract

21.8

18.2

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

4.4

18.0

104

KCE02

NOMESCO Finland

Transluminal endoscopic extraction of calculus from bladder

3.8

17.8

144

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.5

17.8

679

4889

8041/3-C67.9

ICD-O-3

Small cell carcinoma, NOS, of bladder, NOS

+∞

17.7

L01CB01

ATC

etoposide; systemic

+∞

17.7

7343

FHL

Cystectomy and enterocystoplasty

+∞

17.7

L02BX03

ATC

abiraterone; oral

+∞

17.7

L02BX02

ATC

degarelix; parenteral

+∞

17.7

8140/3-C34.9

ICD-O-3

Adenocarcinoma, NOS, of lung, NOS

+∞

17.7

YA1AD

NOMESCO Finland

CT examination of head and neck for dose design of radiotherapy

66.9

17.7

D04.3

ICD-10 Finland

Carcinoma in situ: Skin of other and unspecified parts of face

3.8

17.7

145

TQW99

NOMESCO Finland

Other minor procedure on skin

2.6

17.6

105

418

KFC10

NOMESCO Finland

Bilateral orchiectomy

180.9

17.5

A41.9

ICD-10 Finland

Sepsis, unspecified

2.2

17.3

146

678

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.9

17.3

212

1131

Z93.5

ICD-10 Finland

Cystostomy status

6.6

17.0

YA1BD

NOMESCO Finland

Extensive CT examination of head and neck for dose design of radiotherapy

63.6

16.7

QAE99

NOMESCO Finland

Other excision or repair surgery of skin and subcutaneous tissue in head and neck

4.0

16.7

119

C85.9

ICD-10 Finland

Non-Hodgkin lymphoma, unspecified

+∞

16.7

YN7AD

NOMESCO Finland

CT examination of spine for dose design of radiotherapy

+∞

16.7

C34.19

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung other or unspecified histology

+∞

16.7

KCJ10

NOMESCO Finland

Cutaneous cystoenterostomy

+∞

16.7

1850A

ICD-9 Finland

Malignant neoplasm of prostate[NEOPLASMA MALIGNUM PROSTATAE]

+∞

16.7

WD225

NOMESCO Finland

Demanding therapy of methastized malignancy with hormones

+∞

16.7

C34.30

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung without histology

+∞

16.7

UJF32

NOMESCO Finland

Coloscopy

1.5

16.7

645

4649

SPAT1168

SPAT

Catheterisation training

4.8

16.6

WX002

NOMESCO Finland

Sedation and analgesia

1.6

16.5

478

3236

C18.70

ICD-10 Finland

Malignant tumor of the sigmoid without histology

170.8

16.5

C64

ICD-10 Finland

Malignant neoplasm of kidney, except renal pelvis

170.8

16.5

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

2.2

16.3

134

615

A03

ICPC

Fever

1.8

16.1

269

1580

N30

ICD-10 Finland

Cystitis

2.2

16.1

133

612

B01AB04

ATC

dalteparin; parenteral

2.2

16.1

132

606

L02BG04

ATC

letrozole; oral

30.2

16.1

C91.1

ICD-10 Finland

Chronic lymphocytic leukaemia of B-cell type

47.7

16.0

XJH00

NOMESCO Finland

Transanal ultrasonography

1.8

16.0

252

1457

KWW96

NOMESCO Finland

Other reoperation in urological surgery

60.3

15.8

XKW99

NOMESCO Finland

Other physiological examination of urinary or male genital system

3.4

15.7

167

G04BE30

ATC

drugs used in erectile dysfunction - combinations

+∞

15.6

WB101

NOMESCO Finland

Simple cytostatic neoadjuvant therapy

+∞

15.6

C50.99

ICD-10 Finland

Breast, unspecified

+∞

15.6

ZX013

NOMESCO Finland

Radiotherapy with large shaped fields - SSD therapy

+∞

15.6

352

Kela drug reimbursment

Abiraterone and enzalutamide

+∞

15.6

WX400

NOMESCO Finland

Inhalation anesthesy

2.8

15.6

273

2394A

ICD-9 Finland

Neoplasm of unspecified nature, Bladder

85.5

15.6

S77

ICPC

Malignant neoplasm of skin

22.1

15.5

PJD52

NOMESCO Finland

Block dissection of axillary lymph nodes

160.7

15.5

C34.99

ICD-10 Finland

Malignant tumor in unspecified localization in bronchial and pulmonary other or unspecified histology

160.7

15.5

4078, ,

NOMESCO Finland

160.7

15.5

JA2AT

NOMESCO Finland

Abdominal puncture with ultrasound guidance

5.4

15.4

JN2AE

NOMESCO Finland

Ultrasound examination of lower part of abdomen without contrast

4.0

15.3

109

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

2.4

15.2

104

441

WX702

NOMESCO Finland

Supraglottic ventilation device

2.3

15.1

114

505

KF8AE

NOMESCO Finland

Ultrasound examination of scrotum

2.7

15.0

313

V03AE01

ATC

polystyrene sulfonate; oral

3.0

14.9

219

N21.0

ICD-10 Finland

Calculus in bladder

3.2

14.9

188

JKE18

NOMESCO Finland

Endoscopic internal drainage of bile duct

5.2

14.8

L02BA01

ATC

tamoxifen; oral

31.8

14.8

L02AE04

ATC

triptorelin; parenteral

+∞

14.6

128

Kela drug reimbursment

Cancers of female genital organs

+∞

14.6

C43.50

ICD-10 Finland

Malignant melanoma of the torso without histology

+∞

14.6

K62.7

ICD-10 Finland

Radiation proctitis

+∞

14.6

8090/3-C44.6

ICD-O-3

Basal cell carcinoma, NOS, of skin of upper limb and shoulder

+∞

14.6

C20.99

ICD-10 Finland

Malignant tumor of the rectum other or unspecified histology

+∞

14.6

KCH10

NOMESCO Finland

Enterocystoplasty

80.4

14.6

C34.9

ICD-10 Finland

Malignant neoplasm: Bronchus or lung, unspecified

150.6

14.5

JFB00

NOMESCO Finland

Partial resection of small intestine

3.6

14.5

132

Z08.9

ICD-10 Finland

Follow-up examination after unspecified treatment for malignant neoplasm

36.2

14.4

HA1AA

NOMESCO Finland

X-ray mammography

3.9

14.4

105

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.0

14.4

161

833

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

1.9

14.1

174

930

N45.9

ICD-10 Finland

Orchitis, epididymitis and epididymo-orchitis without abscess

2.4

14.0

384

R59.1

ICD-10 Finland

Generalized enlarged lymph nodes

5.4

14.0

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.8

13.9

218

1257

D41.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Urinary organ, unspecified

53.5

13.8

N02

ICD-10 Finland

Recurrent and persistent haematuria

20.1

13.8

Y69

ICD-10 Finland

Unspecified misadventure during surgical and medical care

3.9

13.8

104

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

2.2

13.7

115

533

7326

FHL

Bladder lavage

13.6

13.7

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.9

13.7

184

1012

C44.71

ICD-10 Finland

Basocellular carcinoma of the skin of the lower extremity including the hip

75.4

13.6

K83.1

ICD-10 Finland

Obstruction of bile duct

4.3

13.6

QAA50

NOMESCO Finland

Cryotherapy of skin of head or neck

4.9

13.6

Z08.1

ICD-10 Finland

Follow-up examination after radiotherapy for malignant neoplasm

+∞

13.5

8120/3-C65.9

ICD-O-3

Transitional cell carcinoma, NOS, of renal pelvis

+∞

13.5

WB123

NOMESCO Finland

Demanding adjuvant cytostatic therapy

+∞

13.5

C20.92

ICD-10 Finland

Malignant tumor of the rectum carcinoma of the adenoma

+∞

13.5

YL1CD

NOMESCO Finland

Very extensive CT examination of pelvis for dose design of radiotherapy

+∞

13.5

WD505

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of methastized malignancy

+∞

13.5

8140/3-C34.1

ICD-O-3

Adenocarcinoma, NOS, of upper lobe, lung

+∞

13.5

C54.11

ICD-10 Finland

Adenocarcinoma of the endometrium

+∞

13.5

WB111

NOMESCO Finland

Multiple neoadjuvant cytostatic therapy

+∞

13.5

1880A

ICD-9 Finland

Malignant neoplasm of bladder, Trigone of urinary bladder

+∞

13.5

8140/3-C67.9

ICD-O-3

Adenocarcinoma, NOS, of bladder, NOS

+∞

13.5

C68.9

ICD-10 Finland

Malignant neoplasm: Urinary organ, unspecified

+∞

13.5

8260/3-C73.9

ICD-O-3

Papillary adenocarcinoma, NOS, of thyroid gland

+∞

13.5

8070/3-C34.3

ICD-O-3

Squamous cell carcinoma, NOS, of lower lobe, lung

+∞

13.5

HA003

NOMESCO Finland

Radiotherapy after partial ablation of mammary gland

+∞

13.5

8120/3-C68.9

ICD-O-3

Transitional cell carcinoma, NOS, of urinary system, NOS

+∞

13.5

N35.9

ICD-10 Finland

Urethral stricture, unspecified

3.0

13.5

194

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

4.1

13.5

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.0

13.5

146

746

N02AA01

ATC

morphine; systemic, rectal

3.1

13.5

189

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.5

13.4

514

3684

7339

FHL

Other measure in this category

40.2

13.1

TKD00

NOMESCO Finland

Dilatation of urethra

4.1

13.0

KD1GB

NOMESCO Finland

Uretrocystogpaphy with X-ray

19.1

12.9

M05BX04

ATC

denosumab; parenteral

2.3

12.9

443

HAC20

NOMESCO Finland

Total mastectomy

50.2

12.8

Z2446

NOMESCO Finland

Social worker

2.0

12.8

140

719

KBB00

NOMESCO Finland

Biopsy of ureter

70.1

12.6

Z08.8

ICD-10 Finland

Follow-up examination after other treatment for malignant neoplasm

70.1

12.6

U01

ICPC

Dysuria/painful urination

2.1

12.5

120

587

C76.8

ICD-10 Finland

Malignant neoplasm of other and ill-defined sites: Overlapping lesion of other and ill-defined sites

+∞

12.5

8380/3-C54.9

ICD-O-3

Endometrioid adenocarcinoma, NOS, of corpus uteri

+∞

12.5

8140/3-C18.2

ICD-O-3

Adenocarcinoma, NOS, of ascending colon

+∞

12.5

8090/3-C44.2

ICD-O-3

Basal cell carcinoma, NOS, of external ear

+∞

12.5

C25.1

ICD-10 Finland

Malignant neoplasm: Body of pancreas

+∞

12.5

C73.91

ICD-10 Finland

Papillary carcinoma of the thyroid gland (thyroid gland)

+∞

12.5

8070/3-C34.1

ICD-O-3

Squamous cell carcinoma, NOS, of upper lobe, lung

+∞

12.5

C90.0

ICD-10 Finland

Multiple myeloma

130.4

12.4

C44.11

ICD-10 Finland

Basocellular carcinoma of the skin of the eyelids including the corner of the eye

130.4

12.4

JAG41

NOMESCO Finland

Repair of stomal hernia, laparoscopic

130.4

12.4

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.6

12.2

314

2062

KE1BE

NOMESCO Finland

Rectal ultrasound examinaiton of prostata

1.6

12.2

327

2169

R4190

NOMESCO Finland

Nutritional therapy

3.1

12.2

158

N05CF01

ATC

zopiclone; oral

1.4

12.2

888

7096

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.5

12.1

422

2962

D23.3

ICD-10 Finland

Benign neoplasm: Skin of other and unspecified parts of face

2.9

12.1

196

I71.4

ICD-10 Finland

Abdominal aortic aneurysm, without mention of rupture

1.9

12.1

153

826

H02AB06

ATC

prednisolone; systemic

1.3

12.1

1210

10129

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.4

12.0

688

5288

JN4JR

NOMESCO Finland

Whole body extensive metabolic PET with CT

14.7

11.8

A28

ICPC

Limited function/disability NOS

1.4

11.7

595

4479

K56.7

ICD-10 Finland

Ileus, unspecified

2.7

11.6

234

KC1GD

NOMESCO Finland

CT cystography of bladder

65.1

11.6

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.5

11.5

399

2796

KH1AA

NOMESCO Finland

Urinary tract X-ray examination without contrast

3.4

11.5

123

N30.4

ICD-10 Finland

Irradiation cystitis

+∞

11.5

CBB50

NOMESCO Finland

Excision of lesion of eyelid and reconstruction using graft or flap

+∞

11.5

C34.00

ICD-10 Finland

Malignant tumor of the main bronchus without histology

+∞

11.5

C18.20

ICD-10 Finland

Malignant tumor of the ascending colon without histology

+∞

11.5

8120/3-C67.0

ICD-O-3

Transitional cell carcinoma, NOS, of trigone of bladder

+∞

11.5

8000/3-C25.9

ICD-O-3

Neoplasm, malignant of pancreas, NOS

+∞

11.5

C34.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bronchus and lung

+∞

11.5

Z85.5

ICD-10 Finland

Personal history of malignant neoplasm of urinary tract

+∞

11.5

8010/3-C67.9

ICD-O-3

Carcinoma, NOS, of bladder, NOS

+∞

11.5

JF1AD

NOMESCO Finland

Small bowel CT

5.0

11.4

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

1.7

11.4

232

1438

PJD81

NOMESCO Finland

Excision of lymph nodes from upper part of neck

120.4

11.4

JAG43

NOMESCO Finland

Repair of stomal hernia with mesh

120.4

11.4

C18.00

ICD-10 Finland

Malignant tumor of the caecum without histology

120.4

11.4

9823/3-C42.1

ICD-O-3

B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow

120.4

11.4

C50

ICD-10 Finland

Malignant neoplasm of breast

120.4

11.4

C76.2

ICD-10 Finland

Malignant neoplasm of other and ill-defined sites: Abdomen

120.4

11.4

N07BA03

ATC

varenicline; oral

2.5

11.4

296

U04

ICPC

Incontinence urine

1.9

11.4

154

850

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.5

11.3

408

2881

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

35.1

11.3

U02

ICPC

Urinary frequency/urgency

1.6

11.2

258

1649

Y83.8

ICD-10 Finland

Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.7

11.1

206

SPAT1255

SPAT

Intravenous administration of medicine

1.7

11.0

185

1091

PD1AD

NOMESCO Finland

CT of abdominal aorta and branches

4.0

10.9

A06AD11

ATC

lactulose; oral

1.4

10.9

527

3929

XW4AT

NOMESCO Finland

Biopsy of other inner organ with ultrasound guidance

43.4

10.9

RD211, ,

NOMESCO Finland

2.2

10.9

449

JAD30

NOMESCO Finland

Repair of incisional hernia using prosthetic material

3.0

10.9

164

S18

ICPC

Laceration/cut

1.3

10.8

1033

8553

WPA10

NOMESCO Finland

Proactive palliative care treatment plan

11.9

10.8

SPAT1088

SPAT

Blood transfusion

5.1

10.8

N99.1

ICD-10 Finland

Postprocedural urethral stricture

3.8

10.7

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.8

10.5

170

992

M05BA02

ATC

clodronic acid; systemic

110.3

10.4

C34.16

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary microcellular carcinoma

+∞

10.4

8070/3-C67.9

ICD-O-3

Squamous cell carcinoma, NOS, of bladder, NOS

+∞

10.4

KE002

NOMESCO Finland

Radical radiotherapy of prostata and seminal vesicles

+∞

10.4

8120/3-C66.9

ICD-O-3

Transitional cell carcinoma, NOS, of ureter

+∞

10.4

C80

ICD-10 Finland

Malignant neoplasm, without specification of site

+∞

10.4

C83.80

ICD-10 Finland

B-cell lymphoma in marginal zone

+∞

10.4

8090/3-C44.1

ICD-O-3

Basal cell carcinoma, NOS, of eyelid

+∞

10.4

C18.01

ICD-10 Finland

Malignant tumor of the caecum invasive carcinoma

+∞

10.4

C50.21

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor

+∞

10.4

WF029

NOMESCO Finland

Radiotherapy of local residive tumor

+∞

10.4

8520/3-C50.9

ICD-O-3

Lobular carcinoma, NOS, of breast, NOS

+∞

10.4

WX892

NOMESCO Finland

Monitored bed care

1.7

10.4

210

1301

QAA25

NOMESCO Finland

Destruction of lesion of head or neck

2.7

10.4

202

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

1.6

10.3

279

1854

TJD00

NOMESCO Finland

Insertion of nasogastric or naso-gastroduodenal tube

3.1

10.3

132

QDE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in lower limb

2.8

10.3

175

KCV02

NOMESCO Finland

Cystoscopic balloon distension of bladder

23.4

10.2

D75

ICPC

Malignant neoplasm colon/rectum

23.4

10.2

N30.8

ICD-10 Finland

Other cystitis

4.2

10.1

WX725

NOMESCO Finland

Noninvasive ventilation

2.0

10.0

110

567

N13.8

ICD-10 Finland

Other obstructive and reflux uropathy

14.6

10.0

N18.8

ICD-10 Finland

Other chronic renal failure

2.0

10.0

107

547

K43.5

ICD-10 Finland

Parastomal hernia without obstruction or gangrene

40.2

10.0

PJD41

NOMESCO Finland

Excision of cervical lymph nodes

7.6

9.9

C03CA01

ATC

furosemide; systemic

1.3

9.8

1248

10690

JDE00

NOMESCO Finland

Gastrojejunostomy

26.1

9.8

R03BB04

ATC

tiotropium bromide; inhalant

1.4

9.8

391

2813

Z43.6

ICD-10 Finland

Attention to other artificial openings of urinary tract

10.6

9.8

JFB31

NOMESCO Finland

Laparoscopic right hemicolectomy

9.5

9.7

G04AC01, ,

ATC

2.3

9.7

294

Z43.5

ICD-10 Finland

Attention to cystostomy

3.1

9.6

132

D40.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Prostate

2.9

9.6

154

SPAT1254

SPAT

Administration of medicine

1.4

9.6

411

2997

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

3.4

9.6

102

KGH10

NOMESCO Finland

Operation for phimosis

2.0

9.5

481

K59.09

ICD-10 Finland

Constipation, unspecified

1.7

9.4

187

1153

L02BG03

ATC

anastrozole; oral

100.3

9.4

U75

ICPC

Malignant neoplasm of kidney

100.3

9.4

KBH96

NOMESCO Finland

Other repair or connection of ureter

100.3

9.4

XGX32

NOMESCO Finland

Bronchoscopic ultrasonography

7.5

9.4

PJ2AT

NOMESCO Finland

Biopsy of lymphnode with ultrasound guidance

17.6

9.4

GDC00

NOMESCO Finland

Lobectomy of lung

17.6

9.4

C32.0

ICD-10 Finland

Malignant neoplasm: Glottis

+∞

9.4

C22.9

ICD-10 Finland

Malignant neoplasm: Liver, unspecified

+∞

9.4

C18.7

ICD-10 Finland

Malignant neoplasm: Sigmoid colon

+∞

9.4

C43.59

ICD-10 Finland

Malignant melanoma of the trunk other or unspecified histology

+∞

9.4

WB131

NOMESCO Finland

Very demanding neoadjuvant cytostatic therapy

+∞

9.4

C34.91

ICD-10 Finland

Malignant tumor in unspecified localization in bronchial and pulmonary epidermoid carcinoma

+∞

9.4

JGB30

NOMESCO Finland

Abdominoperineal excision of rectum

+∞

9.4

8070/3-C44.5

ICD-O-3

Squamous cell carcinoma, NOS, of skin of trunk

+∞

9.4

198

Kela drug reimbursment

Sorafenib

+∞

9.4

YN7BD

NOMESCO Finland

Extensive CT examination of spine for dose design of radiotherapy

+∞

9.4

C44.81

ICD-10 Finland

Overall basocellular carcinoma of the skin

+∞

9.4

C54.10

ICD-10 Finland

Malignant tumor of endometrium without histology

+∞

9.4

7342

FHL

Cystectomy and differential surgery

+∞

9.4

JWA00

NOMESCO Finland

Repair of wound dehiscence in gastroenterological surgery

4.2

9.4

D04.4

ICD-10 Finland

Carcinoma in situ: Skin of scalp and neck

4.7

9.3

I82.88

ICD-10 Finland

Embolism and thrombosis of other specified veins

2.7

9.2

174

ZQZ00

NOMESCO Finland

Treatment of several skin areas

13.7

9.2

EP1AE

NOMESCO Finland

Neck ultrasound examination

2.1

9.1

373

WX306

NOMESCO Finland

Lumbar epidural anesthesy

2.2

9.1

361

J01XE01

ATC

nitrofurantoin; oral

2.8

9.0

159

1544

FHL

Urinary tract endoscopy

15.6

9.0

TKC00

NOMESCO Finland

Needle biopsy of bladder

15.6

9.0

C44.42

ICD-10 Finland

Spinocellular carcinoma of the skin of the scalp and neck

36.8

9.0

KDW98

NOMESCO Finland

Other transluminal endoscopic operations on urethra

36.8

9.0

A18.1

ICD-10 Finland

Tuberculosis of genitourinary system

36.8

9.0

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

2.9

9.0

143

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.4

9.0

444

3316

KFC00

NOMESCO Finland

Unilateral orchiectomy

4.1

9.0

C44.91

ICD-10 Finland

Unspecified localization of basocellular carcinoma of the skin

24.1

8.9

QCE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in upper limb

2.9

8.9

144

D64.9

ICD-10 Finland

Anaemia, unspecified

1.4

8.9

356

2562

TKC50

NOMESCO Finland

Training of urinary bladder

8.0

8.8

XX2RW, ,

NOMESCO Finland

8.0

8.8

K45.8

ICD-10 Finland

Other specified abdominal hernia without obstruction or gangrene

4.9

8.8

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

2.0

8.8

494

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

2.9

8.7

140

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

1.8

8.7

120

667

KH1EE

NOMESCO Finland

Urologic ultrasound examination

7.2

8.7

Z71.8

ICD-10 Finland

Other specified counselling

1.4

8.6

536

4155

KCH42

NOMESCO Finland

Transurethral incision or resection of bladder neck

4.8

8.6

PDQ05

NOMESCO Finland

Insertion of endovascular graft into infrarenal abdominal aorta

2.6

8.5

182

5997A

ICD-9 Finland

Other disorders of urethra and urinary tract, Haematuria

3.4

8.5

Z3226

NOMESCO Finland

Physiotherapist

1.4

8.5

402

2981

JN3KE

NOMESCO Finland

Abdominal ultrasound with added contrast

7.3

8.4

C43.5

ICD-10 Finland

Malignant neoplasm: Malignant melanoma of trunk

90.2

8.4

C43.99

ICD-10 Finland

Unspecified localization of malignant melanoma of the skin other or unspecified histology

90.2

8.4

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.7

8.4

165

1016

UGC18

NOMESCO Finland

Flexible bronchoscopy with biopsy of lung

7.9

8.3

A07AA09

ATC

vancomycin; oral

2.6

8.3

172

C18.41

ICD-10 Finland

Malignant tumor of the transverse colon invasive carcinoma

+∞

8.3

C78.8

ICD-10 Finland

Secondary malignant neoplasm of other and unspecified digestive organs

+∞

8.3

KAD52

NOMESCO Finland

Retrograde ureteronephroscopic destruction of tumour of pelvis of kidney

+∞

8.3

NK6AQ

NOMESCO Finland

Whole body bone SPET with low dose CT

+∞

8.3

C83.1

ICD-10 Finland

Mantle cell lymphoma

+∞

8.3

C18.2

ICD-10 Finland

Malignant neoplasm: Ascending colon

+∞

8.3

C34.92

ICD-10 Finland

Malignant tumor in unspecified localization in bronchial and pulmonary adenocarcinoma

+∞

8.3

ZX095

NOMESCO Finland

Combined chemoradiotherapy

+∞

8.3

8140/3-C34.3

ICD-O-3

Adenocarcinoma, NOS, of lower lobe, lung

+∞

8.3

C34.01

ICD-10 Finland

Malignant tumor of the main bronchial epidermoid carcinoma

+∞

8.3

WF001

NOMESCO Finland

Preoperative radiotherapy

+∞

8.3

1523, ,

Kela drug reimbursment

+∞

8.3

8097/3-C44.9

ICD-O-3

Basal cell carcinoma, nodular of skin, NOS

+∞

8.3

8720/3-C44.9

ICD-O-3

Malignant melanoma, NOS, of skin, NOS

+∞

8.3

3054, ,

Kela drug reimbursment

+∞

8.3

GDB21

NOMESCO Finland

Thoracoscopic segmental resection of lung

+∞

8.3

C83.3

ICD-10 Finland

Diffuse large B-cell lymphoma

+∞

8.3

KBJ00

NOMESCO Finland

Cutaneous ureterostomy

+∞

8.3

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

1.8

8.3

130

751

R95

ICPC

Chron obstructive pulmonary disease

1.9

8.3

109

597

HAB40

NOMESCO Finland

Wedge excision of mammary gland

10.8

8.3

T81.9

ICD-10 Finland

Unspecified complication of procedure

2.7

8.2

151

WX600

NOMESCO Finland

Single shot through catheter

7.5

8.1

GDB11

NOMESCO Finland

Thoracoscopic wedge resection of lung

7.5

8.1

T81.2

ICD-10 Finland

Accidental puncture and laceration during a procedure, not elsewhere classified

3.9

8.1

N17.8

ICD-10 Finland

Other acute renal failure

2.5

8.1

192

R39.1

ICD-10 Finland

Other difficulties with micturition

1.9

8.1

509

JFF10

NOMESCO Finland

Loop enterostomy

11.7

8.1

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.5

8.1

302

2146

K63.1

ICD-10 Finland

Perforation of intestine (nontraumatic)

3.0

8.0

114

DAB10

NOMESCO Finland

Partial excision of auricle

22.1

8.0

D37.6

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts

3.6

8.0

KDE20

NOMESCO Finland

Removal of foreign body from urethra

3.9

8.0

KWD00

NOMESCO Finland

Reoperation for superficial haemorrhage in urological surgery

7.2

7.9

KED33

NOMESCO Finland

Transurethral incision of prostate

2.2

7.9

314

KC1AE

NOMESCO Finland

Percutaneous ultrasound examination of urinary bladder

6.6

7.9

TQW40

NOMESCO Finland

Remowal of suture of skin

1.8

7.8

120

690

E87.5

ICD-10 Finland

Hyperkalaemia

2.1

7.8

356

M01AE01

ATC

ibuprofen; systemic, rectal

1.3

7.7

1978

18171

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

1.8

7.7

108

604

PJ5AN

NOMESCO Finland

Localisation of sentinell lymphnode with isotope imaging

45.1

7.7

KDD32

NOMESCO Finland

Urethroscopic destruction of tumour of urethra

45.1

7.7

ZXC50

NOMESCO Finland

Cryotherapy

2.4

7.7

222

R11

ICD-10 Finland

Nausea and vomiting

1.6

7.7

169

1071

N30.1

ICD-10 Finland

Interstitial cystitis (chronic)

3.5

7.7

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

1.8

7.6

103

570

DHB00

NOMESCO Finland

Excision of lesion of external nose

8.0

7.6

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.3

7.6

955

8109

D41.3

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Urethra

25.0

7.6

8130/1-C67.9

ICD-O-3

Papillary urothelial neoplasm of low malignant potential of bladder, NOS

25.0

7.6

PJ3AT

NOMESCO Finland

Cytology of lymphnode with ultrasound guidance

8.9

7.5

JN1CD

NOMESCO Finland

Very extensive CT examination of upper part of abdomen

4.2

7.5

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.3

7.4

611

4918

KEB00

NOMESCO Finland

Biopsy of prostate

3.1

7.4

KB1DG

NOMESCO Finland

Very extensive MRI of urinary tract

80.2

7.4

C34.39

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung other or unspecified histology

80.2

7.4

C77.0

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck

80.2

7.4

ZXE50

NOMESCO Finland

More than nine and less than 12 hours

2.5

7.4

177

Z93.3

ICD-10 Finland

Colostomy status

7.6

7.4

SPAT1109

SPAT

Analgesia with portable analgesic pump

6.0

7.4

R59.0

ICD-10 Finland

Localized enlarged lymph nodes

2.6

7.3

154

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.4

7.3

351

2607

KDD30

NOMESCO Finland

Destruction of tumour of urethra

+∞

7.3

C18.30

ICD-10 Finland

Malignant tumor of flexura hepatica without histology

+∞

7.3

C50.42

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor

+∞

7.3

C34.0

ICD-10 Finland

Malignant neoplasm: Main bronchus

+∞

7.3

C18.99

ICD-10 Finland

Malignant tumor in unspecified location in the colon other or unspecified histology

+∞

7.3

C79.39

ICD-10 Finland

Secondary malignant tumor of the meninges, ventricle or other part of the brain

+∞

7.3

8130/3-C67.2

ICD-O-3

Papillary urothelial carcinoma of lateral wall of bladder

+∞

7.3

C77.1

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes

+∞

7.3

8140/3-C25.9

ICD-O-3

Adenocarcinoma, NOS, of pancreas, NOS

+∞

7.3

C18.72

ICD-10 Finland

Malignant tumor of sigmoid carcinoma of adenoma

+∞

7.3

C79.7

ICD-10 Finland

Secondary malignant neoplasm of adrenal gland

+∞

7.3

C18.61

ICD-10 Finland

Malignant tumor of the colon descending invasive carcinoma

+∞

7.3

C60.9

ICD-10 Finland

Malignant neoplasm: Penis, unspecified

+∞

7.3

8140/3-C18.9

ICD-O-3

Adenocarcinoma, NOS, of colon, NOS

+∞

7.3

C80.99

ICD-10 Finland

Malignant tumor without specified localization or histology

+∞

7.3

8140/3-C18.0

ICD-O-3

Adenocarcinoma, NOS, of cecum

+∞

7.3

C77.4

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Inguinal and lower limb lymph nodes

+∞

7.3

G04BE09

ATC

vardenafil; oral

+∞

7.3

C82.1

ICD-10 Finland

Follicular lymphoma grade II

+∞

7.3

9680/3-C77.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of lymph node, NOS

+∞

7.3

C79.31

ICD-10 Finland

Secondary malignant tumor of the cerebellum

+∞

7.3

C83.39

ICD-10 Finland

Diffuse non-Hodgkin's large cell lymphoma UNS

+∞

7.3

HB000

NOMESCO Finland

Profylactic radiotherapy of mammary gland

+∞

7.3

C77.9

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph node, unspecified

+∞

7.3

WC125

NOMESCO Finland

Demanding cytostatic therapy of local tumor recidive

+∞

7.3

8380/3-C54.1

ICD-O-3

Endometrioid adenocarcinoma, NOS, of endometrium

+∞

7.3

WX610

NOMESCO Finland

Patient controlled analgesia

6.8

7.3

JN2DG

NOMESCO Finland

Very extensive MRI examination of lower part of abdoment with high intensity magnet

9.4

7.3

G04BD11

ATC

fesoterodine; oral

2.0

7.3

373

Z72.0

ICD-10 Finland

Tobacco use

2.4

7.2

197

D40.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Testis

3.8

7.2

ZX050

NOMESCO Finland

Stereotactic radiotherapy

15.8

7.2

1549

FHL

Other endoscopy

15.8

7.2

D05.1

ICD-10 Finland

Intraductal carcinoma in situ

30.1

7.1

OAB50, ,

SPAT

1.7

7.1

127

763

PJD45

NOMESCO Finland

Excision of inguinal lymph nodes

12.0

7.1

A09AA02

ATC

multienzymes (lipase, protease etc.); oral

2.4

7.0

200

KK1XE

NOMESCO Finland

Other ultrasound examination of retroperitoneal space and genito-urinary tract

10.0

7.0

T83.0

ICD-10 Finland

Mechanical complication of urinary (indwelling) catheter

4.2

7.0

P01AB01

ATC

metronidazole; oral, rectal

1.3

7.0

739

6137

ZZA00

NOMESCO Finland

Split skin graft

2.1

7.0

304

Z00.0

ICD-10 Finland

General medical examination

1.3

6.9

436

3378

HAB99

NOMESCO Finland

Other partial excision of mammary gland

7.5

6.9

C44.22

ICD-10 Finland

Spinocellular carcinoma of the skin of the outer ear and the outer ear canal

40.1

6.8

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

1.9

6.7

405

B03XA02

ATC

darbepoetin alfa; parenteral

2.2

6.7

236

ZXA00

NOMESCO Finland

Right side

1.3

6.7

662

5447

R84

ICPC

Malignant neoplasm bronchus/lung

22.5

6.7

GD2CT

NOMESCO Finland

Cytology of the lungs with CT guidance

22.5

6.7

PD3YT

NOMESCO Finland

Pelvic artery PTA with stent

2.5

6.7

168

UJG02

NOMESCO Finland

Proctoscopy

2.4

6.6

187

KH1AT

NOMESCO Finland

Urinary tract cathetrisation with ultrasound guidance

4.0

6.6

D37.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Colon

2.7

6.6

122

K56.0

ICD-10 Finland

Paralytic ileus

2.4

6.6

169

JN5ER

NOMESCO Finland

PET-CT of receptors in whole body

12.3

6.6

SPAT1153

SPAT

Removal of sutures

1.3

6.6

670

5535

XKD06

NOMESCO Finland

Physiologic investigation of micturition

1.9

6.5

452

N20.0

ICD-10 Finland

Calculus of kidney

2.1

6.5

292

JFG10

NOMESCO Finland

Closure of loop colostomy without resection

6.8

6.5

SPAT1211

SPAT

Application of soft bandage

1.5

6.5

191

1294

J01DA01

ATC

[U] cefalexin

1.2

6.5

1515

13666

C44.40

ICD-10 Finland

Malignant tumor of the skin of the scalp and neck without histology

69.9

6.4

22330

ICD-8 Finland

Benign neoplasm of kidney and other urinary organs, Bladder

69.9

6.4

KBD22

NOMESCO Finland

Retrograde ureteroscopic destruction of tumour of ureter

69.9

6.4

D41.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other urinary organs

69.9

6.4

C44.20

ICD-10 Finland

Malignant tumor of the skin of the outer ear and of the outer ear canal without histology

69.9

6.4

YA1VG

NOMESCO Finland

MRI examination of head and neck with high intesity magnet for dose design of radiotherapy

14.3

6.4

SPAT1172

SPAT

Guidance concerning hydration

1.9

6.4

427

SPAT1301

SPAT

No procedures

1.2

6.3

772

6505

D37.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Rectum

3.6

6.3

WF099

NOMESCO Finland

Other radiotherapy

11.0

6.3

G04CA01

ATC

alfuzosin; oral

1.3

6.3

508

4073

ZX100

NOMESCO Finland

Oral

2.6

6.3

131

JN2BG

NOMESCO Finland

MRI examination of lower part of abdoment with high intensity magnet

9.3

6.3

TGE00

NOMESCO Finland

Needle biopsy of mediastinum

9.3

6.3

ZXA05

NOMESCO Finland

Left side

1.3

6.3

613

5035

K52.0

ICD-10 Finland

Gastroenteritis and colitis due to radiation

18.0

6.3

JA3CT

NOMESCO Finland

Cathetrisation of abdominal cavity with CT guidance

18.0

6.3

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

0.7

6.3

213

2984

C18.79

ICD-10 Finland

Malignant tumor of the sigmoid or other unspecified histology

+∞

6.2

C43.51

ICD-10 Finland

Malignant melanoma of the trunk originating in lentigo maligna

+∞

6.2

8260/3-C64.9

ICD-O-3

Papillary adenocarcinoma, NOS, of kidney, NOS

+∞

6.2

WF090

NOMESCO Finland

Profylactic radiotherapy

+∞

6.2

YG1CD

NOMESCO Finland

Very extensive CT examination of thorax for dose design of radiotherapy

+∞

6.2

OAA41

NOMESCO Finland

Health check based on individual needs

+∞

6.2

C57.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of female genital organs

+∞

6.2

8070/3-C32.9

ICD-O-3

Squamous cell carcinoma, NOS, of larynx, NOS

+∞

6.2

C34.15

ICD-10 Finland

Malignant tumor of the anterior, bronchial or lung other non-microcellular carcinoma

+∞

6.2

1744A

ICD-9 Finland

Malignant neoplasm of female breast, Upper-outer quadrant

+∞

6.2

8140/3-C80.9

ICD-O-3

Adenocarcinoma, NOS, of unknown primary site

+∞

6.2

C34.80

ICD-10 Finland

Malignant overall tumor of bronchus and lung without histology

+∞

6.2

8041/3-C34.9

ICD-O-3

Small cell carcinoma, NOS, of lung, NOS

+∞

6.2

C50.91

ICD-10 Finland

Malignant tumor in another specified localization in ductal mammary gland

+∞

6.2

WB303

NOMESCO Finland

Simple adjuvant therapy of malignancy with biomodifiers

+∞

6.2

8070/3-C44.2

ICD-O-3

Squamous cell carcinoma, NOS, of external ear

+∞

6.2

C18.31

ICD-10 Finland

Malignant tumor of flexura hepatica invasive carcinoma

+∞

6.2

8130/2-C67.2

ICD-O-3

Papillary urothelial carcinoma, non-invasive of lateral wall of bladder

+∞

6.2

WB203

NOMESCO Finland

Simple adjuvant hormone therapy of malignancy

+∞

6.2

C43.53

ICD-10 Finland

Malignant melanoma of the torso nodular

+∞

6.2

KBC00

NOMESCO Finland

Ureterectomy

+∞

6.2

Z08.2

ICD-10 Finland

Follow-up examination after chemotherapy for malignant neoplasm

+∞

6.2

C43.60

ICD-10 Finland

Malignant melanoma of the upper extremity including the shoulder without histology

+∞

6.2

C83.00

ICD-10 Finland

Lymphocytic lymphoma

+∞

6.2

C15.5

ICD-10 Finland

Malignant neoplasm: Lower third of oesophagus

+∞

6.2

9680/3-C67.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of bladder, NOS

+∞

6.2

C50.51

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor

+∞

6.2

8090/3-C44.7

ICD-O-3

Basal cell carcinoma, NOS, of skin of lower limb and hip

+∞

6.2

C34.82

ICD-10 Finland

Malignant overall tumor of bronchial and pulmonary adenocarcinoma

+∞

6.2

C18.29

ICD-10 Finland

Malignant tumor of the ascending colon or other unspecified histology

+∞

6.2

Z85.3

ICD-10 Finland

Personal history of malignant neoplasm of breast

+∞

6.2

8140/3-C18.4

ICD-O-3

Adenocarcinoma, NOS, of transverse colon

+∞

6.2

C60.1

ICD-10 Finland

Malignant neoplasm: Glans penis

+∞

6.2

PJD99

NOMESCO Finland

Excision of other lymph nodes

+∞

6.2

JFC20

NOMESCO Finland

Other enterocolostomy

26.7

6.2

9732/3-C42.1

ICD-O-3

Plasma cell myeloma of bone marrow

26.7

6.2

S37.2

ICD-10 Finland

Injury of bladder

26.7

6.2

XF400

NOMESCO Finland

ECG with 12 standard connections

1.3

6.2

487

3888

JN2AD

NOMESCO Finland

CT examination of lower part of abdomen

7.0

6.2

PJA10

NOMESCO Finland

Exploration of lymph nodes

6.3

6.1

JA1AE

NOMESCO Finland

Ultrasound examination of groin and abdominal wall

2.3

6.1

200

R19.0

ICD-10 Finland

Intra-abdominal and pelvic swelling, mass and lump

3.0

6.1

SPAT1263

SPAT

Sampling

1.2

6.1

920

7934

R60.0

ICD-10 Finland

Localized oedema

1.4

6.0

299

2231

K65.0

ICD-10 Finland

Acute peritonitis

2.4

6.0

152

WW200, ,

SPAT

0.7

6.0

276

3676

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3049717) Cytology report of Urine Cyto stain

1457

914

29.78

307.65

5.7

1.9

—

(3026008) Bacteria identified in Urine by Culture

1649

6164

4.67

307.65

6.3

3.2

—

(3002256) Pathology report gross observation

878

1264

9.37

307.65

1.7

1.1

—

(4035726) Immunohistochemistry procedure

473

463

11.91

307.65

1.3

1.2

—

(40768804) Tissue Pathology biopsy report

1366

5115

4.04

304.52

3.2

1.6

—

(3002582) Erythrocytes [#/volume] in Urine

1382

6510

3.06

193.56

9.7

3.1

323.79

122.64

e6/l

1.91

1206

5113

(3000850) Epithelial cells [#/volume] in Urine

1075

4589

3.08

176.23

5.8

2.5

5.13

3.53

e6/l

3.58

1014

4087

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1599

8464

2.88

176.01

3.8

2.4

—

(3018095) Leukocytes [#/volume] in Urine

1442

7340

2.84

169.21

10.5

3.5

337.46

120.17

e6/l

2.92

1250

5422

(3044640) Blood type and Crossmatch panel - Blood

1233

5782

2.91

169.03

3.4

2.3

—

(3030467) Casts [#/volume] in Urine by Automated count

1224

5839

2.84

160.77

9.7

3.0

0.46

0.48

e6/l

0.11

1084

4523

(3031040) Bacteria [#/volume] in Urine by Automated count

2093

13205

2.89

157.50

12.6

4.4

1495.46

1800.39

e6/l

0.09

284

(36304419) Bacteria [Presence] in Urine

1170

5537

2.81

154.89

9.7

3.0

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

818

3335

2.99

141.13

9.5

2.8

1.20

1.55

e6/l

1.29

619

1935

(3026782) Osmolality of Urine

978

4391

2.81

140.95

6.7

2.8

555.22

559.35

mosm/kgh2o

0.28

893

3727

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

849

3569

2.91

138.14

8.7

2.6

2.19

1.21

e6/l

5.03

643

2152

(3023368) Bacteria identified in Blood by Culture

1294

6757

2.60

136.90

5.6

4.0

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

934

4401

2.62

119.16

3.3

2.2

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

728

3051

2.82

116.84

4.8

2.4

0.80

0.82

mmol/l

8.66

688

2767

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1606

9846

2.34

112.49

8.4

3.7

10.66

13.24

umol/l

10.42

1550

9177

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

374

1075

3.83

112.10

3.2

1.4

49.44

2.82

ug/l

0.83

316

800

(3037467) Urinalysis macro (dipstick) panel - Urine

2011

13668

2.40

109.46

8.4

4.1

—

(3009343) pH of Capillary blood

463

1643

3.14

99.09

5.3

3.7

7.41

0.07

186

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

466

1665

3.12

98.54

5.4

3.7

4.97

5.17

kpa

6.18

451

1556

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

451

1591

3.15

97.41

5.2

3.7

0.36

1.84

mmol/l

10.96

342

1132

(3000991) Gas panel - Venous blood

509

1932

2.96

96.64

10.3

7.1

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

1422

8828

2.15

89.90

5.7

3.8

32.60

34.58

g/l

24.78

1336

7991

(3021447) Carbon dioxide [Partial pressure] in Venous blood

582

2470

2.68

88.83

5.0

3.5

5.90

5.85

kpa

0.55

570

2368

(3002032) Base excess in Venous blood by calculation

580

2465

2.67

88.23

5.0

3.6

1.34

1.96

mmol/l

3.46

508

2026

(3022313) Gas panel - Capillary blood

358

1196

3.26

84.17

5.5

3.9

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

1558

10232

2.07

82.46

10.9

5.5

4.90

4.63

e9/l

2.56

1385

8715

(3014111) Lactate [Moles/volume] in Serum or Plasma

494

2066

2.66

76.82

8.5

5.9

1.41

1.49

mmol/l

0.45

481

1987

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

303

980

3.32

74.82

5.8

4.3

23.85

24.71

mmol/l

5.17

288

885

(3003458) Phosphate [Moles/volume] in Serum or Plasma

606

2880

2.38

71.30

5.5

5.4

1.04

mmol/l

0.03

571

2603

(3020779) Urea [Moles/volume] in Serum or Plasma

498

2206

2.50

68.18

5.5

6.4

11.78

12.28

mmol/l

0.71

468

2053

(3013826) Glucose [Moles/volume] in Serum or Plasma

1757

12553

1.95

67.86

7.1

4.6

7.03

mmol/l

0.02

1693

11772

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

390

1536

2.76

67.77

2.4

1.9

0.21

0.19

g/l

2.96

363

1368

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

317

1126

3.02

66.58

4.7

4.0

23.51

24.12

mmol/l

2.73

312

1078

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1420

9498

1.93

66.34

8.0

5.4

1.20

mmol/l

3.03

1314

8424

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1519

10469

1.90

63.99

8.6

5.8

1.20

1.21

mmol/l

2.39

1304

8804

(3009261) Glucose [Presence] in Urine by Test strip

1431

9683

1.90

63.70

6.3

3.7

0.00

estimate

0.50

290

1535

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

328

1224

2.88

62.91

10.9

7.8

23.33

24.36

mmol/l

6.58

313

1143

(3035350) Ketones [Presence] in Urine by Test strip

1419

9608

1.90

62.73

6.3

3.7

0.00

estimate

1.34

324

1783

(3022217) INR in Platelet poor plasma by Coagulation assay

1611

11388

1.88

62.00

18.6

22.2

1.31

1.48

inr

9.59

413

3135

(3021601) Nitrite [Presence] in Urine by Test strip

1406

9530

1.89

61.59

8.2

4.9

0.00

estimate

-0.00

294

1609

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

317

1192

2.85

59.85

10.7

9.3

—

(3003396) Base excess in Arterial blood by calculation

577

2879

2.24

59.54

8.8

6.3

-0.29

1.27

mmol/l

12.83

471

2206

(3027801) Oxygen [Partial pressure] in Arterial blood

576

2876

2.24

59.31

8.8

6.3

13.07

11.14

kpa

14.97

545

2707

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

576

2877

2.24

59.26

8.9

6.3

5.07

5.03

kpa

0.52

550

2713

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

364

1478

2.66

59.23

10.7

7.8

0.53

0.68

12.01

356

1461

(3030981) Hyaline casts [#/volume] in Urine by Automated count

344

1361

2.72

58.91

5.9

2.6

0.73

0.33

e6/l

1.83

339

1337

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

364

1486

2.65

58.56

10.5

7.7

1.09

1.39

8.09

356

1470

(3016502) Oxygen saturation in Arterial blood

533

2592

2.28

58.42

9.3

6.6

96.14

94.70

6.76

517

2485

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

1948

14835

1.88

57.13

10.6

5.2

87.97

77.88

u/l

8.67

1871

13601

(3002173) Hemoglobin [Mass/volume] in Arterial blood

483

2280

2.33

56.66

9.8

7.1

114.59

122.16

g/l

14.79

477

2229

(3015377) Calcium [Moles/volume] in Serum or Plasma

1010

6354

1.88

54.07

4.5

2.1

2.33

2.34

mmol/l

0.67

877

5231

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

490

2382

2.26

53.39

3.6

2.4

231.74

241.08

u/l

0.74

464

2177

(40761535) Cells panel - Urine sediment

432

2001

2.35

52.70

6.0

3.2

—

(3015736) pH of Urine

1162

7752

1.81

50.70

5.8

3.4

5.57

5.79

0.73

258

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

349

1530

2.45

47.95

1.6

—

(40760892) CBC W Ordered Manual Differential panel - Blood

1237

8514

1.76

47.75

6.2

5.3

—

(3022096) Basophils/100 leukocytes in Blood

1221

8390

1.76

47.27

6.0

5.1

0.60

0.63

1.51

1154

7647

(3019069) Monocytes/100 leukocytes in Blood

1256

8711

1.75

46.99

6.2

5.5

9.10

9.03

0.28

1186

7955

(3006504) Eosinophils/100 leukocytes in Blood

1250

8665

1.75

46.79

5.9

5.1

2.73

2.99

3.37

1180

7902

(3002030) Lymphocytes/100 leukocytes in Blood

1270

8858

1.75

46.40

6.2

5.3

23.29

24.94

5.64

1202

8112

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

967

6273

1.79

45.16

3.5

2.3

120.87

61.43

u/l

0.50

917

5751

(3006315) Basophils [#/volume] in Blood

1311

9303

1.72

44.44

5.6

4.8

0.04

e9/l

0.08

1109

7911

(3013115) Eosinophils [#/volume] in Blood

1344

9607

1.72

44.32

5.8

5.0

0.20

0.22

e9/l

1.82

1147

8242

(3019198) Lymphocytes [#/volume] in Blood

1329

9478

1.71

44.14

5.8

4.9

1.84

1.76

e9/l

0.63

1147

8206

(3001604) Monocytes [#/volume] in Blood

1303

9251

1.72

43.93

5.6

4.8

0.69

0.65

e9/l

4.47

1105

7858

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

7.16

42.77

1.4

1.3

—

(3018010) Neutrophils/100 leukocytes in Blood

1239

8747

1.70

42.14

6.0

5.1

60.96

59.58

3.31

1170

8018

(3033658) Prothrombin time (PT) actual/Normal

749

4612

1.83

40.92

5.6

3.6

84.25

78.66

7.72

737

4474

(3035637) Corticotropin [Mass/volume] in Plasma

113

6.22

40.36

1.4

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

221

852

2.72

39.40

2.6

2.7

0.35

0.34

u/ml

0.29

109

499

(3028626) Oxygen [Partial pressure] in Capillary blood

176

600

3.05

39.34

3.4

2.9

8.42

7.68

kpa

6.97

176

586

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

130

374

3.58

38.22

2.5

1.7

756.91

28.75

u/ml

0.73

117

297

(1616796) Gas panel - Central venous blood

160

535

3.10

36.97

3.9

3.8

—

(3024354) Oxygen [Partial pressure] in Venous blood

390

2045

2.04

34.01

3.6

3.0

4.19

4.40

kpa

1.42

377

1948

(40761539) Cells [Type] in Urine sediment by Light microscopy

9.19

32.99

1.3

1.1

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

186

723

2.67

32.56

4.0

3.2

23.38

24.84

mmol/l

4.57

186

707

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

234

1042

2.35

30.66

1.8

1.7

2.83

1.89

ug/l

0.61

203

892

(3003694) ABO and Rh group [Type] in Blood

676

4347

1.71

30.56

1.3

1.2

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

300

1490

2.12

30.11

1.6

1.5

—

(3041096) Erythrocytes [Presence] in Urine by Automated

733

4843

1.68

29.84

5.7

3.5

—

(40758558) Short blood count panel - Blood

665

4283

1.71

29.79

8.5

4.3

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

715

4720

1.67

29.10

6.1

3.6

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1031

7506

1.56

27.79

7.2

3.9

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

314

1633

2.03

27.78

4.5

3.3

123.66

129.70

g/l

4.38

309

1593

(3042936) Bacteria identified in Isolate by Culture

496

3009

1.77

27.26

2.0

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

565

3564

1.72

27.03

2.4

1.8

29.78

30.44

2.22

552

3450

(3021901) Oxygen saturation in Capillary blood

140

520

2.77

26.76

3.6

2.7

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

278

1420

2.05

25.79

5.1

3.2

24.50

25.00

mmol/l

1.31

273

1367

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

510

3175

1.73

25.45

2.8

2.7

20.05

22.12

2.73

431

2637

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

842

5963

1.57

25.11

2.4

2.3

3.10

3.02

mg/l

0.41

727

4956

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

2210

19181

1.56

24.95

28.7

16.0

38.45

28.07

mg/l

31.77

2048

15561

(3036481) Cortisol [Moles/volume] in Serum or Plasma

274

1414

2.03

24.68

4.2

1.7

415.38

369.48

nmol/l

3.01

261

1252

(3022948) Iron [Moles/volume] in Serum or Plasma

564

3647

1.67

24.34

2.7

2.6

11.05

12.22

umol/l

3.62

526

3326

(3004789) Transferrin [Mass/volume] in Serum or Plasma

527

3352

1.69

24.20

2.7

2.6

2.20

2.22

g/l

0.28

484

3040

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

281

3.27

23.35

5.4

6.1

12.56

12.17

mg/l

0.35

255

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

605

4045

1.62

22.71

2.0

1.8

—

(3019225) pH of Specimen

368

2169

1.79

22.02

5.2

3.8

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

772

5495

1.54

22.01

3.7

2.5

35.69

39.47

u/l

0.45

731

5135

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

179

3.74

21.24

1.1

1.2

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

572

3828

1.61

21.24

3.7

2.2

2.48

2.44

mmol/l

9.73

493

3222

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

274

1497

1.91

20.85

1.9

1.7

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

278

1527

1.90

20.82

2.5

2.2

39.00

37.11

u/l

0.18

233

1242

(3004809) Band form neutrophils/100 leukocytes in Blood

257

3.21

20.50

2.2

2.9

1.99

1.54

0.26

212

(3029937) Albumin [Presence] in Urine by Test strip

760

5482

1.51

20.08

7.2

4.0

0.00

estimate

0.20

239

1509

(40768800) Prostate Pathology biopsy report

160

3.80

19.80

1.3

1.1

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

993

7577

1.46

19.75

3.1

2.9

170.87

159.94

ug/l

0.76

915

6805

(3045414) Leukocytes [Presence] in Urine

169

789

2.21

19.74

3.1

1.9

—

(3022621) pH of Urine by Test strip

255

1406

1.89

18.84

4.4

3.0

—

(3018418) pH of Serum or Plasma

803

5935

1.48

18.60

4.5

3.3

7.39

7.40

0.87

166

1052

(3021589) Normoblasts [#/volume] in Blood

1027

8029

1.42

17.39

13.6

8.9

0.00

e9/l

0.22

818

6465

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

196

1026

1.97

16.89

2.2

1.8

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

2010

17676

1.41

16.61

29.4

14.9

66.17

70.68

ml/min/173m2

17.53

1807

14295

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

164

810

2.08

16.60

3.0

2.9

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

4.91

16.59

1.2

37.65

24.13

iu/l

1.09

(40767503) Oxygen content in Capillary blood by calculation

115

493

2.38

16.44

3.0

2.5

16.75

16.36

0.44

262

(3014051) Protein [Presence] in Urine by Test strip

118

514

2.35

16.27

4.5

2.5

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

207

3.13

15.76

2.6

2.1

4.48

1.74

u/field

0.85

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

314

1940

1.69

15.71

2.8

2.2

10.68

9.50

umol/l

0.26

269

1667

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1201

9802

1.37

15.19

2.4

2.2

91.67

90.52

pmol/l

0.36

762

5350

(3019060) Gas panel - Arterial blood

289

1768

1.70

14.98

5.2

4.7

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

179

949

1.94

14.88

2.2

1.7

—

(3000330) Specific gravity of Urine by Test strip

215

1218

1.82

14.55

6.5

3.5

—

(40761511) CBC panel - Blood by Automated count

2173

19542

1.39

14.49

28.2

15.8

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

217

2.94

13.96

2.5

1.7

135.92

26.23

u/ml

1.20

198

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

119

3.65

13.54

2.5

1.8

5.86

1.81

u/field

2.00

(3017181) Myelocytes/100 leukocytes in Blood

245

1476

1.72

13.42

3.3

3.4

0.97

0.90

0.19

118

430

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

261

1604

1.68

13.28

4.4

2.5

59.55

58.45

ml/min/173m2

0.19

139

642

(3019550) Sodium [Moles/volume] in Serum or Plasma

2257

20541

1.38

13.14

35.4

19.8

139.17

139.74

mmol/l

19.26

2212

19866

(3021440) Promyelocytes/100 leukocytes in Blood

236

1416

1.72

13.12

3.3

3.4

0.11

0.08

0.30

113

371

(3008757) Leukocyte morphology finding [Identifier] in Blood

199

2.95

12.96

2.9

3.2

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

2259

20578

1.38

12.95

35.4

19.9

4.08

4.03

mmol/l

11.80

2213

19871

(3009214) Lutropin [Units/volume] in Serum or Plasma

270

2.63

12.57

1.2

1.3

15.09

7.54

u/l

4.25

218

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

231

2.76

12.48

2.6

3.2

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

3.78

11.98

1.2

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

3.78

11.98

1.2

—

(3013512) EKG study

840

6680

1.35

11.84

5.3

4.5

—

(40768441) Liver Pathology biopsy report

5.38

11.80

1.4

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

5.53

11.62

5.1

1.1

17.37

37.12

u/ml

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

137

3.24

11.61

1.2

1.3

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

179

2.94

11.59

2.3

2.8

65.10

60.58

0.81

144

(3002179) Metamyelocytes/100 leukocytes in Blood

219

1334

1.69

11.52

3.2

3.3

0.58

0.70

0.49

108

369

(3024928) Oxygen saturation in Venous blood

106

513

2.10

11.40

2.9

3.0

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

204

1226

1.71

11.28

1.5

1.82

1.49

g/l

4.63

178

1040

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

227

2.67

11.23

1.2

1.1

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

228

2.66

11.14

1.3

1.2

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

141

3.15

11.09

1.2

1.3

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

229

2.65

11.05

1.3

1.2

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

229

2.65

11.05

1.3

1.2

—

(3009542) Hematocrit [Volume Fraction] of Blood

2272

20916

1.34

10.71

42.6

23.1

37.31

39.86

45.15

2100

18928

(3024522) Salmonella sp identified in Specimen by Organism specific culture

233

2.60

10.68

1.3

1.2

—

(3013707) Erythrocyte sedimentation rate by Westergren method

1627

14327

1.29

10.61

4.3

4.0

18.79

13.71

mm/h

19.27

1483

12978

(3007461) Platelets [#/volume] in Blood

2272

20929

1.34

10.58

41.9

22.9

243.03

229.07

e9/l

15.45

2209

20106

(3024731) MCV [Entitic volume]

2272

20930

1.34

10.57

41.7

22.9

91.90

92.02

0.54

2230

20371

(3026361) Erythrocytes [#/volume] in Blood

2272

20931

1.34

10.56

41.8

22.9

4.22

4.45

e12/l

63.95

2196

20008

(3010813) Leukocytes [#/volume] in Blood

2272

20931

1.34

10.56

41.8

22.9

7.73

7.03

e9/l

22.56

2200

20015

(3000963) Hemoglobin [Mass/volume] in Blood

2272

20933

1.34

10.53

42.1

23.1

125.80

135.38

g/l

114.71

2224

20378

(3035941) MCH [Entitic mass]

2271

20930

1.34

10.45

41.6

22.8

30.30

30.62

13.92

2227

20372

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

994

8220

1.31

10.42

3.0

3.3

2407.80

2130.67

ng/l

0.70

874

7134

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1479

12888

1.29

10.37

4.9

4.0

3.11

2.27

ug/l

1.33

1248

11376

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

231

2.58

10.35

1.3

1.2

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1270

10859

1.29

10.31

3.6

3.0

66.57

54.49

u/l

2.47

1158

9720

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

131

709

1.88

10.30

1.3

1.2

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

238

2.55

10.25

1.3

1.2

—

(3012501) Base excess in Blood by calculation

104

521

2.03

10.24

5.0

4.7

2.37

2.71

mmol/l

0.51

345

(3037121) Protein [Mass/volume] in Urine

132

726

1.85

9.89

2.6

2.4

0.38

0.31

g/l

0.48

272

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

408

2.14

9.79

1.2

1.3

—

(3007853) Bacteria identified in Skin by Aerobe culture

348

2449

1.47

9.78

1.8

—

(3025159) Blasts/100 leukocytes in Blood

211

1329

1.63

9.77

3.4

3.5

0.08

0.11

0.22

292

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

610

4739

1.36

9.74

4.4

307.97

629.22

ng/l

1.85

534

4203

(3006184) Hemoglobin [Mass/volume] in Capillary blood

109

567

1.96

9.67

2.4

2.1

128.22

131.15

g/l

0.54

421

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

458

2.06

9.61

1.6

1.5

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

174

1050

1.70

9.51

5.8

4.9

0.88

0.86

0.32

169

995

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2189

20162

1.31

9.50

13.6

9.3

24.49

25.56

u/l

1.88

2106

19056

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

390

2823

1.44

9.45

1.9

1.8

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1110

9416

1.28

9.31

4.7

4.4

51.65

95.53

ng/l

1.42

941

7460

(3023520) Reticulocytes [#/volume] in Blood

321

2246

1.48

9.28

2.1

73.40

66.83

e9/l

0.66

256

1753

(1761482) Bacteria [#/volume] in Urine by Culture

130

728

1.82

9.21

7.3

4.0

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

175

1068

1.68

9.17

5.7

4.9

1.66

1.63

0.11

170

1015

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

387

2822

1.42

8.99

1.9

1.8

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

513

1.96

8.91

1.4

1.5

—

(40761536) Microorganisms panel - Urine sediment

230

1517

1.56

8.79

6.9

3.8

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

252

1704

1.52

8.60

8.2

6.9

23.71

24.40

mmol/l

1.52

241

1633

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

7.34

8.43

1.4

1.3

—

(3010421) pH of Blood

110

604

1.85

8.33

4.9

4.6

7.41

7.42

0.50

102

534

(3044889) 12 lead EKG panel

1574

14040

1.25

8.28

4.7

4.4

—

(40768795) Lymph node Pathology biopsy report

7.53

8.14

1.2

—

(3020630) Protein [Mass/volume] in Serum or Plasma

286

2019

1.46

7.89

2.2

1.6

65.65

66.37

g/l

0.80

255

1764

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

983

8343

1.26

7.89

2.3

2.2

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

13.04

7.87

7.8

1.2

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

121

699

1.76

7.78

1.2

1.3

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

9.41

7.77

1.1

—

(3045424) Erythrocytes [Presence] in Urine

269

2.22

7.49

1.6

1.4

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

237

1630

1.49

7.47

3.9

102.87

105.42

ng/l

0.12

198

1365

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

185

1214

1.56

7.26

1.5

1.4

—

(3027945) Reticulocytes/100 erythrocytes in Blood

399

3036

1.36

7.14

2.1

2.0

1.86

1.74

1.22

344

2597

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

242

1690

1.47

7.07

4.7

3.0

1.22

mmol/l

0.76

222

1435

(3017143) Hepatitis C virus Ab [Presence] in Serum

181

1200

1.54

6.80

1.5

—

(3047181) Lactate [Moles/volume] in Blood

125

759

1.67

6.76

6.4

6.0

1.36

1.38

mmol/l

0.08

110

679

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

266

2.12

6.47

1.2

—

(3022145) Colonoscopy Study observation

243

1730

1.44

6.43

1.3

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

469

1.83

6.42

2.9

2.4

1.97

1.85

mg/l

0.45

401

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

304

2254

1.39

6.39

5.5

3.5

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

209

1454

1.47

6.25

1.4

1.5

—

(3002385) Erythrocyte distribution width [Ratio]

1720

15820

1.20

5.63

33.6

18.1

15.64

15.52

0.36

1684

15394

(3039000) Anion gap in Blood

512

1.74

5.62

7.8

7.1

11.31

11.45

mmol/l

0.14

467

(3018572) Chloride [Moles/volume] in Blood

512

1.74

5.62

7.8

7.1

105.64

105.13

mmol/l

0.53

467

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

282

2.00

5.59

2.4

2.2

34.85

24.11

mg/l

0.37

(3023183) Ammonium ion [Moles/volume] in Plasma

468

1.77

5.59

2.1

2.3

31.33

34.66

umol/l

0.53

412

(3011648) Oxygen content in Venous blood

160

2.33

5.41

1.5

1.8

9.08

10.41

1.20

160

(3019150) Specific gravity of Urine by Refractometry

565

4681

1.25

5.29

8.0

4.0

1.02

kg/l

0.89

113

722

(3017446) Testosterone [Moles/volume] in Serum or Plasma

188

1331

1.44

5.17

1.9

2.1

10.00

14.93

nmol/l

12.36

160

1131

(3006462) Nitrate [Presence] in Urine

2.64

4.97

5.2

3.1

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

247

2.00

4.92

3.9

3.6

—

(3033799) Differential panel - Peritoneal fluid

3.34

4.87

1.2

1.7

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

3.34

4.87

1.8

2.5

—

(3005719) IgG [Mass/volume] in Serum or Plasma

161

1121

1.46

4.85

2.1

2.0

10.41

10.95

g/l

1.00

149

1008

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

270

1.94

4.81

1.3

1.7

2.56

4.00

iu/l

—

(3017732) Neutrophils [#/volume] in Blood

172

1225

1.43

4.61

3.1

3.2

4.58

5.87

e9/l

1.67

121

881

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

2.81

4.54

2.2

1.4

—

(3020891) Body temperature

151

1056

1.45

4.47

5.7

4.9

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

119

794

1.52

4.45

2.4

1.5

72.64

53.59

mg/l

0.84

635

(3026493) Urate [Moles/volume] in Serum or Plasma

679

5838

1.21

4.40

2.9

2.7

7416.82

7161.64

umol/l

0.04

586

4914

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

405

4915

0.80

4.35

1.6

1.41

1.30

mmol/l

1.16

342

4012

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

118

794

1.50

4.25

2.4

1.5

43.31

38.45

mg/l

0.36

633

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

136

943

1.46

4.23

2.4

2.2

846.12

555.54

ug/l

0.53

130

890

(3043409) Potassium [Moles/volume] in Arterial blood

122

834

1.48

4.09

4.8

4.3

4.14

3.96

mmol/l

2.09

117

822

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

3.09

4.07

1.3

2.5

1914.14

41995.17

e6/l

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

163

1179

1.40

4.04

2.5

—

(3043410) Blood group antigens tested for on Red Blood Cells

2.94

4.00

1.8

1.7

—

(40768443) Skin Pathology biopsy report

108

725

1.51

3.96

1.3

1.2

—

(3021960) Folate [Moles/volume] in Serum or Plasma

664

5754

1.20

3.92

1.7

1.6

19.05

19.20

nmol/l

0.08

577

4864

(3042631) Mycobacterium sp identified in Specimen

307

1.77

3.84

2.7

2.8

—

(3004588) Protein electrophoresis panel - Serum or Plasma

224

1721

1.32

3.81

2.0

1.5

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

2.84

3.78

1.3

2.6

1822.10

405.14

e6/l

—

(3028026) IgM [Mass/volume] in Serum or Plasma

129

908

1.44

3.75

1.6

1.3

1.61

1.07

g/l

1.08

119

810

(40768806) Pleura Pathology biopsy report

251

1.84

3.74

1.5

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

2.74

3.74

1.6

2.3

—

(21494814) CD8 cells/100 lymphocytes in Specimen

4.59

3.74

1.9

3.3

—

(3022806) Fractional oxyhemoglobin in Capillary blood

289

1.78

3.68

1.9

89.14

89.04

0.03

284

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

5.01

3.68

2.1

3.6

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

617

1.52

3.63

1.6

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

473

3997

1.22

3.63

1.7

1.6

2.02

1.45

mg/l

2.00

404

3150

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

106

724

1.48

3.61

1.9

2.1

178.56

109.66

ug/min

0.55

417

(3012441) Differential panel - Pleural fluid

269

1.80

3.60

1.3

1.5

—

(3019309) Folate [Moles/volume] in Red Blood Cells

633

5501

1.19

3.59

1.8

1081.15

1134.87

nmol/l

0.77

468

4105

(40765096) Chromosome analysis panel by Banding

4.77

3.55

1.5

1.0

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

512

1.56

3.45

1.5

226.34

272.11

ug/g

1.21

321

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

787

6995

1.17

3.39

2.9

2.8

0.78

0.75

ug/l

0.24

552

5017

(3028308) Erythrocytes [#/volume] in Pleural fluid

290

1.73

3.36

1.3

1.5

16353.61

88343.27

e6/l

1.63

172

(3023199) Leukocytes [#/volume] in Pleural fluid

322

1.69

3.30

1.3

1.5

1062.80

2161.63

e6/l

0.85

233

(21494755) Public health laboratory ask at order entry panel

503

0.49

3.23

1.2

1.4

—

(3014271) Vancomycin [Susceptibility]

177

1.93

3.23

2.8

2.9

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

378

1.62

3.23

3.0

2.3

—

(1761868) Lipid panel - Serum or Plasma

441

5151

0.83

3.22

3.1

3.6

—

(3003434) Protein [Mass/volume] in Pleural fluid

371

1.63

3.20

1.5

31.05

27.12

g/l

1.76

327

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

132

964

1.38

3.16

2.0

1.4

3.87

3.78

g/l

0.29

114

836

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

2.63

3.12

2.3

1.4

0.33

0.23

e9/l

0.64

(3051651) Icteric interference index of Serum or Plasma

2.25

3.12

3.9

3.7

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

132

968

1.38

3.09

2.0

1.4

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

132

968

1.38

3.09

2.0

1.4

7.45

7.44

g/l

0.01

113

840

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

125

910

1.39

3.06

2.1

1.4

10.05

10.49

g/l

0.52

107

779

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

685

1.44

3.02

3.6

2.9

4.24

4.34

pmol/l

0.42

580

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

107

762

1.42

2.98

1.7

1.4

36.59

37.23

g/l

0.40

634

(4281824) Cell count and differential, peritoneal fluid

2.47

2.95

1.1

1.2

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

603

5302

1.17

2.95

1.7

27022117.37

27584991.00

pmol/l

0.01

507

4256

(3013727) Leukocytes other/100 leukocytes in Blood

2.83

2.91

1.8

3.0

59.27

61.87

0.18

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

110

792

1.40

2.89

1.9

1.5

0.64

0.48

g/l

0.22

660

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

123

903

1.38

2.88

2.1

1.4

3.10

2.92

g/l

1.05

105

776

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

806

7265

1.15

2.81

2.2

215.77

251.83

u/l

0.78

755

6771

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

409

1.55

2.79

1.5

—

(3052851) Hemolysis interference index of Serum or Plasma

607

1.44

2.74

4.6

3.7

—

(40768793) Breast Pathology biopsy report

3.00

2.69

1.3

1.1

—

(3020876) Protein [Mass/time] in 24 hour Urine

267

1.66

2.59

1.9

2.1

1.18

1.57

g/24h

0.57

125

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

107

2.06

2.56

1.1

—

(40760888) Immunoglobulin light chains.free panel - Serum

591

1.43

2.55

2.6

1.5

—

(3004451) EKG impression Narrative

121

1.99

2.54

1.3

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

208

1.74

2.53

1.3

1.8

358.69

293.39

mu/l

0.64

194

(3051593) INR in Capillary blood by Coagulation assay

164

1.84

2.52

6.8

10.3

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

309

1.59

2.49

3.8

3.5

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

181

1.77

2.42

1.3

9.88

11.20

u/l

0.43

164

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

211

1.71

2.42

1.0

1.1

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

1112

0.71

2.38

1.3

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

668

1.39

2.36

1.2

1.1

101.66

100.61

iu/ml

0.01

242

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

315

2679

1.20

2.30

4.4

5.0

32.47

33.14

0.47

208

1771

(3044927) Protein electrophoresis panel - Urine

316

1.56

2.29

1.1

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

313

1.54

2.15

3.0

3.1

62.69

60.11

0.57

313

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

242

1.62

2.15

1.3

338.89

277.39

u/l

0.37

227

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

2.03

2.15

1.4

1.5

6.93

8.06

u/l

0.13

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

250

1.61

2.15

1.4

1.5

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

314

1.54

2.13

1.1

1.2

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

243

1.61

2.12

7.8

4.5

1344.33

603.87

iu/ml

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

820

7526

1.12

2.09

2.1

78.18

77.85

nmol/l

0.11

719

6435

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

160

1.76

2.09

1.3

—

(3045788) Cell count panel - Pleural fluid

245

1.60

2.06

1.4

1.6

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

286

1.55

2.02

1.2

1.3

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

666

1.35

1.95

1.8

1.4

0.00

g/l

-0.00

588

(3051611) Lipemic interference index of Serum or Plasma

202

1.64

1.94

3.5

3.4

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

2.73

1.93

2.9

1.2

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

711

1.33

1.92

1.8

1.4

0.01

0.05

g/l

1.15

631

(3030905) Polymorphonuclear cells [#/volume] in Blood

306

1.51

1.92

2.8

2.9

5.10

4.73

e9/l

0.31

306

(3037756) Immunofixation for Serum or Plasma

474

1.40

1.87

1.2

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

654

1.34

1.86

1.8

1.4

0.00

g/l

-0.00

584

(3009445) Proteinase 3 Ab [Units/volume] in Serum

125

988

1.28

1.86

1.6

1.5

22.97

20.85

u/ml

—

(3003181) Sodium [Moles/volume] in Urine

374

1.45

1.86

1.4

54.68

61.97

mmol/l

0.74

295

(3026389) Candida sp identified in Specimen by Organism specific culture

190

1.64

1.83

1.6

1.4

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

307

2663

1.17

1.82

2.3

2.4

4.70

7.20

ug/l

3.88

254

2267

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

168

1.67

1.80

1.3

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

3.05

1.79

1.7

1.3

—

(3000494) Fungus identified in Specimen by Culture

244

2083

1.19

1.76

1.5

1.4

—

(3000093) Morphology [Interpretation] in Blood Narrative

234

1.54

1.70

1.1

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

2.00

1.69

1.0

1.1

1.49

0.86

u/ml

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

308

1.47

1.67

1.6

1.4

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

2.50

1.66

3.7

2.4

0.10

0.35

u/field

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.58

1.65

1.1

—

(3003338) MCHC [Mass/volume]

1596

15283

1.09

1.65

37.4

21.0

329.57

332.29

g/l

27.00

1571

15055

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

286

1.47

1.61

1.6

1.3

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

286

1.47

1.61

1.6

1.3

—

(3025941) Bacteria identified in Stool by Culture

108

858

1.27

1.59

1.2

—

(3044007) Cell count panel - Peritoneal fluid

2.33

1.58

1.4

2.3

—

(3002619) Bacteria identified in Specimen by Culture

2.69

1.58

1.3

1.2

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

2.69

1.58

1.1

2.5

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

2.20

1.56

1.5

1.3

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

2.27

1.55

1.5

1.3

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

423

1.38

1.55

1.6

1.4

—

(3017704) Immunofixation for Urine

145

1.66

1.53

1.3

1.2

—

(40768797) Stomach Pathology biopsy report

287

2515

1.15

1.52

1.2

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

138

1.67

1.51

2.2

2.5

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

2.16

1.50

1.5

1.3

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

2.16

1.50

1.5

1.3

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

1787

17250

1.09

1.45

4.5

4.2

1.98

2.09

mu/l

2.73

1590

15239

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

205

1.52

1.39

1.0

1.1

—

(3008295) Osmolality of Serum or Plasma

173

1.56

1.39

1.2

1.4

284.40

276.17

mosm/kgh2o

0.82

114

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

150

1.60

1.37

1.1

247.33

140.66

miu/ml

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

2.94

1.36

1.0

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

410

1.35

1.32

1.1

25.25

22.57

u/l

0.21

346

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

463

0.69

1.32

1.8

1.5

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

2.35

1.29

2.4

1.6

187.63

173.35

ng/l

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

153

1.57

1.28

1.3

1.2

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

153

1.57

1.28

1.3

1.2

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

153

1.57

1.28

1.3

1.2

—

(3040151) Glucose [Moles/volume] in Capillary blood

329

1.37

1.23

3.8

30.1

7.85

7.88

mmol/l

0.02

263

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

1.97

1.21

1.5

1.1

1.58

2.41

u/l

—

(3014891) Appearance of Pleural fluid

2.04

1.21

1.3

1.1

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

700

1.25

1.21

1.8

1.7

33.82

38.03

u/l

0.93

559

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

1.80

1.20

1.4

1.3

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

1.80

1.20

1.4

1.3

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

238

1.43

1.19

2.2

1.7

1.01

1.03

g/l

0.02

185

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1089

10369

1.08

1.19

4.3

3.9

21.49

24.69

10.55

550

5263

(4034850) Laboratory test

769

0.78

1.17

18.0

11.5

—

(3048879) Bone marrow aspiration report

1.93

1.16

1.1

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

446

1.31

1.16

1.6

1.4

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

2.50

1.15

1.0

1.1

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

1.73

1.14

1.0

1.2

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

216

1.44

1.13

1.2

1.3

122.80

111.39

u/ml

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

280

3114

0.89

1.13

1.2

3.36

2.06

u/ml

0.31

777

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

503

1.28

1.10

1.5

1.6

13.27

12.13

iu/ml

0.03

119

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

218

2455

0.88

1.08

1.2

50.84

17.28

u/ml

0.67

846

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

586

1.25

1.06

1.6

1.3

—

(3000492) Spirometry study

165

1433

1.16

1.05

1.5

1.6

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

587

1.25

1.05

1.6

1.3

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

129

1.55

1.05

3.6

3.7

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

123

0.49

1.05

1.3

1.1

—

(3000012) Reticulocyte production index

357

1.32

1.05

1.7

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

170

1.47

1.04

1.5

1.4

13.40

14.45

u/l

0.48

163

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

315

1.34

1.02

1.5

1.3

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

179

1.46

1.02

1.2

1.3

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

509

1.26

1.02

1.3

1.1

—

(3004775) Volume in Urine collected for unspecified duration

238

1.39

1.02

1.9

2.3

743.78

643.14

0.54

142

(21494890) Protein electrophoresis panel - 24 hour Urine

238

1.39

1.02

1.7

1.2

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

281

1.36

1.01

1.7

1.3

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

164

1.47

0.98

1.0

1.2

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

2.17

0.98

2.2

1.7

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

236

2622

0.89

0.96

1.2

45.98

45.39

iu/ml

0.02

798

(44816559) Phosphatidylethanol [Mass/volume] in Blood

281

0.67

0.94

1.3

1.2

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

268

1.35

0.93

1.6

1.4

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

561

1.23

0.93

3.9

3.6

42.14

30.92

mg/l

1.13

394

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

218

1.38

0.91

1.2

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1393

13473

1.06

0.90

3.6

3.3

15.10

pmol/l

0.02

1225

11810

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

2.07

0.89

3.3

1.1

16.85

74.96

u/l

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

2.07

0.89

1.7

2.3

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

1879

18342

1.06

0.88

6.8

6.9

42.53

41.82

mmol/mol

1.66

1697

16592

(3007566) Smooth muscle Ab [Titer] in Serum

403

1.27

0.88

1.3

1.1

72.00

70.74

titre

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

439

1.26

0.88

1.1

1.4

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

211

1.38

0.88

1.0

1.1

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

2.00

0.87

1.2

1.1

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

1.82

0.85

2.5

1.4

—

(42529406) Shigella sp [Presence] in Stool by Culture

513

1.23

0.85

1.3

1.2

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

504

1.23

0.85

1.3

1.2

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

343

1.29

0.85

1.7

1.3

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

1.59

0.84

1.0

1.3

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

1.59

0.84

1.0

1.3

—

(3024263) Appearance of Synovial fluid

137

1.46

0.83

1.4

—

(3019977) pH of Arterial blood

154

1.43

0.83

2.5

2.1

7.42

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

275

1.31

0.81

1.5

1.3

—

(3020682) Albumin/Creatinine [Ratio] in Urine

827

7896

1.06

0.81

3.8

3.9

15.50

9.20

mg/mmol

3.38

602

5235

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

172

1.40

0.80

1.3

—

nmol/l

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

1.56

0.77

1.1

1.4

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

1.70

0.75

1.1

1.2

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

1.70

0.75

2.9

2.0

—

(3028433) Virus identified in Specimen by Culture

1.70

0.75

1.0

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

209

1.34

0.75

1.7

1.4

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

209

1.34

0.75

1.7

1.4

—

(4146454) Self-monitoring of blood glucose

271

1.29

0.74

1.9

2.7

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

397

1.24

0.72

1.2

1.4

—

(3000285) Sodium [Moles/volume] in Blood

1.80

0.72

1.0

1.1

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

1.62

0.71

2.6

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.92

0.70

1.4

1.0

—

(40762365) Oxygen content in Arterial blood by calculation

1.71

0.69

3.9

2.3

12.50

15.26

ml/dl

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

101

1.49

0.69

1.1

—

4.29

iu/ml

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

101

1.49

0.69

1.1

1.0

3.09

4.07

u/ml

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

118

1.44

0.69

1.2

1.1

0.90

0.88

u/ml

—

(3035320) C reactive protein [Mass/volume] in Body fluid

135

1.41

0.68

3.9

2.5

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

275

1.27

0.67

1.2

—

(3037522) Nuclear Ab [Titer] in Serum

229

2099

1.10

0.67

1.3

349.57

475.89

titre

1.14

467

(3008401) Mugwort IgE Ab [Units/volume] in Serum

102

1.47

0.67

1.1

1.0

1.11

0.96

u/ml

—

(4062490) Immunoglobulin typing, IgG

153

1.37

0.66

1.5

1.2

—

(3012565) Volume of 24 hour Urine

1.51

0.65

1.7

2.0

2357.14

1885.37

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

1.61

0.65

1.0

1.1

0.53

1.52

u/ml

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.72

0.63

1.8

2.2

—

(3023419) Bacteria identified in Sputum by Culture

386

1.22

0.63

2.1

2.5

—

(4200892) Spirometry reversibility

160

1449

1.11

0.61

1.5

1.4

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

675

1.16

0.60

1.5

1.3

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

610

1.17

0.60

1.3

1.2

—

(3035933) Granulocytes/100 leukocytes in Blood

0.00

0.60

0.0

1.2

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

200

1.30

0.60

1.2

209.93

283.78

u/ml

0.96

116

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

1925

18909

1.05

0.60

5.2

6.27

6.20

mmol/l

1.35

1717

16750

(3001019) Free T4 and TSH panel - Serum or Plasma

243

0.74

0.59

1.4

1.7

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

185

0.70

0.58

1.1

1.2

6.64

7.95

mmol/l

—

147

(3009508) Creatinine [Moles/volume] in Urine

776

7471

1.05

0.57

3.1

3.2

6.99

7.66

mmol/l

5.45

627

6172

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.71

0.57

1.5

1.1

—

(3012516) Albumin [Mass/volume] in Urine

771

7422

1.05

0.57

3.3

3.2

424.45

228.98

mg/l

0.68

578

5031

(3027456) Digoxin [Moles/volume] in Serum or Plasma

679

0.85

0.57

2.9

3.1

0.77

0.82

nmol/l

0.55

525

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

116

0.60

0.57

1.1

1.0

—

(36660697) Celiac disease serology panel - Serum

1103

0.88

0.57

1.2

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

1.67

0.56

8.7

12.1

5.32

4.94

mmol/l

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

720

0.86

0.56

1.9

—

(3019832) Treponema pallidum Ab [Presence] in Serum

450

0.82

0.55

1.2

1.3

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

183

0.71

0.55

1.0

372.71

341.41

ng/l

—

110

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

183

0.71

0.55

1.0

582.50

625.98

ng/l

—

106

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

183

0.71

0.55

1.0

44.71

46.63

ng/l

—

107

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

458

1.18

0.55

1.2

1.3

0.24

0.23

g/l

0.37

432

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

257

1.25

0.55

1.2

1.3

—

18.44

—

(3020650) Glucose [Presence] in Urine

1.58

0.54

1.3

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

151

1.33

0.53

1.5

1.2

0.34

0.46

g/l

0.67

115

(3028192) IgG subclass 2 [Mass/volume] in Serum

151

1.33

0.53

1.5

1.2

2.93

3.03

g/l

0.05

115

(3027135) IgG subclass 1 [Mass/volume] in Serum

151

1.33

0.53

1.5

1.2

6.01

7.27

g/l

0.75

113

(3011985) Renin [Units/volume] in Plasma

222

1.26

0.53

1.4

1.3

42.73

79.59

mu/l

1.16

194

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

1.45

0.53

2.0

2.2

28.67

44.52

—

(3032057) Clostridioides difficile [Presence] in Stool

1.52

0.52

2.1

1.9

—

(3020961) Endomysium IgA Ab [Titer] in Serum

608

0.85

0.52

1.1

—

311.63

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

1.43

0.52

2.6

1.3

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

1.46

0.50

1.3

1.1

—

(3034426) Prothrombin time (PT)

1.46

0.50

1.2

1.3

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

118

1.36

0.50

1.1

1.3

—

(1002224) Polysomnography panel

432

0.83

0.49

1.0

1.1

—

(3006270) Folate [Moles/volume] in Blood

234

1.24

0.49

1.2

1.3

295.50

317.72

nmol/l

0.22

177

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

262

1.22

0.48

1.2

1.3

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

235

1.24

0.47

1.1

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

137

1.31

0.47

2.0

1.4

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

169

1562

1.09

0.46

1.6

1.73

1.66

0.29

138

1265

(3029075) Extractable nuclear Ab panel - Serum

1.43

0.46

1.0

—

(3008898) HLA-B27 [Presence]

308

0.81

0.45

1.0

1.1

—

(3044941) Cell count panel - Synovial fluid

384

0.83

0.45

1.4

1.3

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

340

0.82

0.44

1.1

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

469

1.15

0.44

1.2

1.3

1.14

1.13

g/l

0.06

440

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

294

1.19

0.42

1.8

1.4

66.12

67.29

0.07

193

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

0.00

0.41

0.0

1.1

—

(3044009) aPTT.lupus sensitive (LA screen)

0.00

0.41

0.0

1.2

—

(3019174) dRVVT (LA screen)

0.00

0.41

0.0

1.2

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.00

0.41

0.0

1.1

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

0.00

0.41

0.0

1.1

—

2.10

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

0.00

0.41

0.0

1.5

—

(3005322) IgE [Units/volume] in Serum or Plasma

846

0.89

0.41

1.3

504.06

271.16

u/ml

0.58

783

(40757373) Influenza virus identified in Isolate

1.36

0.41

2.6

1.4

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

0.00

0.40

0.0

1.0

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

0.00

0.40

0.0

4.3

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

1.36

0.39

1.2

1.1

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

0.00

0.39

0.0

1.3

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

0.00

0.39

0.0

1.0

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

106

1.32

0.39

1.6

1.4

—

(21494434) Karyotype in Bone marrow

178

1.24

0.38

1.1

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

158

0.76

0.37

1.3

1.6

—

2192.00

—

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

1.35

0.37

1.0

1.1

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

107

1.31

0.37

1.1

2.0

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

107

1.31

0.37

1.6

1.4

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

312

2976

1.05

0.37

12.6

8.2

—

(3045142) Bone marrow Pathology biopsy report

145

1.24

0.33

1.0

1.1

—

(3006653) Thiamine [Moles/volume] in Blood

100

1.30

0.33

1.6

1.2

144.62

139.94

nmol/l

0.17

100

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

136

1.25

0.33

1.6

1.3

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

0.67

0.33

1.2

1.1

32.17

41.69

mg/l

—

(3002079) Sodium [Moles/time] in 24 hour Urine

1.35

0.32

1.1

1.3

115.60

173.27

mmol/24h

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

398

1.13

0.31

1.8

1.5

—

(3036670) Protein [Mass/volume] in Synovial fluid

1.30

0.31

1.3

1.1

30.36

38.99

g/l

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

1.35

0.31

1.0

—

(3010375) cycloSPORINE [Mass/volume] in Blood

1.35

0.31

46.7

22.2

130.71

122.11

ug/l

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

609

0.90

0.30

1.1

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

1836

18535

0.97

0.29

4.4

4.9

4.20

4.23

mmol/l

0.58

1629

16765

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

1814

18313

0.97

0.29

4.4

4.8

1.32

1.35

mmol/l

2.44

1600

16429

(3010838) Calcium [Moles/time] in 24 hour Urine

250

1.16

0.29

1.9

1.7

4.13

4.58

mmol/24h

0.32

210

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

222

1.17

0.29

1.1

1.0

—

(3021788) Differential panel - Synovial fluid

420

1.12

0.29

1.6

1.4

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

108

0.74

0.29

1.6

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

1.32

0.28

1.5

1.3

63.60

94.20

umol/l

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

1.27

0.27

1.1

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

553

0.90

0.27

1.2

0.28

0.74

u/ml

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

542

0.90

0.27

1.5

1.6

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

120

0.75

0.27

1.3

1.5

13.22

15.62

umol/l

—

109

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

551

0.91

0.26

1.1

—

2.12

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

234

1.15

0.26

1.7

1.3

18729.43

321246.80

e6/l

3.96

171

(3007164) IgA [Mass/volume] in Serum or Plasma

276

2657

1.04

0.25

1.4

1.3

3.00

2.96

g/l

0.07

170

1476

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

207

1.16

0.25

1.8

1.5

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

464

1.10

0.24

1.5

1.2

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

1.26

0.24

1.1

1.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

1.26

0.24

1.1

1.0

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

1.28

0.24

1.0

1.2

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

0.70

0.24

1.2

1.1

228.67

304.48

mg/l

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

208

1.15

0.23

1.0

1.3

248.76

290.12

pmol/l

0.26

170

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

152

1446

1.05

0.23

1.3

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.25

0.22

3.2

2.2

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.25

0.22

3.2

2.2

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

1.25

0.22

1.2

1.1

—

(40758292) HTLV I+II Ab panel - Serum

0.00

0.21

0.0

1.3

—

(3032868) Hemoglobin electrophoresis panel in Blood

0.00

0.21

0.0

1.4

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.5

—

366.36

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

0.00

0.21

0.0

1.0

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

0.00

0.21

0.0

1.3

—

(3020393) Adenovirus Ag [Presence] in Stool

0.00

0.21

0.0

1.0

—

(3044242) Glucose [Moles/volume] in Arterial blood

156

0.83

0.21

1.8

1.5

—

(3013762) Body weight Measured

0.00

0.21

0.0

1.3

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

209

0.86

0.21

1.2

1.4

—

120.36

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.16

0.21

1.0

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

0.00

0.21

0.0

1.2

—

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

0.00

0.20

0.0

1.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

1.25

0.20

1.0

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

393

1.09

0.20

1.2

5.00

3.75

u/ml

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.20

0.19

2.0

1.4

7.98

9.52

ug/l

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.20

0.19

1.2

1.3

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

166

1.14

0.17

1.1

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

522

1.07

0.17

1.6

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

1.21

0.17

1.1

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

299

0.90

0.17

3.8

3.7

369.52

332.61

umol/l

0.83

247

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

131

0.84

0.17

1.0

1.1

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

0.73

0.17

5.4

8.6

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

0.72

0.17

1.2

1.1

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

164

1697

0.96

0.16

1.5

—

(3048689) Calprotectin [Mass/mass] in Stool

162

1564

1.04

0.15

2.3

2.1

200.89

195.58

ug/g

0.05

133

1217

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

0.79

0.15

1.2

1.1

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

1766

17756

0.98

0.15

4.0

4.3

1.36

1.26

mmol/l

7.41

1538

15779

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

643

1.06

0.15

1.4

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

102

1.18

0.15

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

102

1.18

0.15

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

102

1.18

0.15

1.1

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

0.79

0.14

1.0

1.1

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

0.79

0.14

1.1

1.2

5.72

6.43

mmol/l

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

0.79

0.14

2.0

2.3

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

181

0.88

0.14

1.1

1.2

7.33

6.21

u/ml

—

(3016750) Collection duration of Urine

150

1.13

0.14

2.1

2.0

506.00

499.40

min

—

106

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

108

0.83

0.13

1.0

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

161

1.12

0.12

1.2

1.1

—

71.69

—

(3023410) Appearance of Cerebral spinal fluid

142

1.13

0.12

1.7

1.3

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

346

1.07

0.11

1.3

1.2

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

178

0.90

0.11

1.1

1.2

—

48.06

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

188

0.90

0.11

1.1

1.2

1.71

2.55

u/ml

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

484

1.05

0.11

1.1

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

105

1.14

0.11

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

105

1.14

0.11

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

105

1.14

0.11

1.1

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

115

0.87

0.10

1.4

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

125

0.88

0.10

1.3

1.4

168.14

161.51

pmol/l

0.07

125

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

125

0.88

0.10

1.1

2.58

2.13

mmol/l

0.38

113

(3044290) Cell count panel - Cerebral spinal fluid

329

1.06

0.10

1.3

1.1

—

(4094501) Cardiovascular stress test using bicycle ergometer

527

1.04

0.09

1.1

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

165

1.09

0.08

1.5

1.4

—

(40768446) Kidney Pathology biopsy report

0.83

0.08

1.4

1.6

—

(3000475) Leukocytes [#/volume] in Synovial fluid

598

1.04

0.07

1.7

1.5

32191.80

15788.29

e6/l

0.90

434

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

0.84

0.07

1.0

1.1

—

(3011288) Drugs identified in Urine by Screen method

1.07

0.07

2.8

1.5

—

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

1.04

0.07

3.1

2.4

40450.00

42602.60

ug/l

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

1.04

0.07

1.1

1.7

—

(3016018) Differential panel - Cerebral spinal fluid

153

0.91

0.07

1.5

1.1

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

0.89

0.06

2.0

1.1

—

(3003327) Ova and parasites identified in Stool by Light microscopy

416

0.96

0.06

1.4

1.6

—

(3035880) pH of Pleural fluid

148

1.08

0.06

1.6

1.4

—

(3016879) Cocaine [Presence] in Urine

110

0.91

0.05

2.2

1.2

—

(3032773) Endomysium IgG Ab [Titer] in Serum

120

0.92

0.05

1.1

—

(3039443) Prostate specific Ag panel - Serum or Plasma

409

1.03

0.03

1.3

1.6

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

370

0.97

0.03

1.3

21.68

39.69

e6/l

0.40

297

(3017315) Amylase [Enzymatic activity/volume] in Urine

1.09

0.03

1.2

203.90

335.15

u/l

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

369

0.97

0.02

1.4

1299.29

910.69

e6/l

0.16

309

(3047007) Chlamydophila sp Ab [Presence] in Serum

152

1.05

0.02

1.4

1.3

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

248

0.97

0.02

1.1

1.0

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

328

0.97

0.02

1.5

1.4

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

113

1.06

0.01

1.1

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

123

1.06

0.01

1.0

—

(3017569) Oxygen content in Arterial blood

143

1.05

0.01

1.5

1.7

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

163

1.04

0.01

1.0

1.1

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

363

1.02

0.01

1.3

1.4

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

226

0.97

0.00

2.3

1.3

16.41

23.47

0.94

153

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1.06

0.00

1.3

1.6

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

1.06

0.00

2.0

1.2

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

1914

19129

1.00

0.00

5.0

5.5

2.40

2.44

mmol/l

1.41

1692

17229

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

168

1.01

0.00

1.5

1.2

—

(3000764) Benzodiazepines [Presence] in Urine

110

1.00

0.00

2.1

1.2

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

197

1.01

0.00

1.1

1.3

—

(3002523) Influenza virus A Ag [Presence] in Specimen

101

0.99

0.00

1.0

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

101

0.99

0.00

1.0

1.1

—

(3004616) Nuclear Ab [Presence] in Serum

237

1.01

0.00

1.2

—

(3027008) Opiates [Presence] in Urine

112

0.98

0.00

2.1

1.2

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

254

2539

1.00

0.00

2.9

3.4

258.50

290.55

ng/l

0.59

232

2349

(3014148) Varicella zoster virus Ab [Titer] in Serum

109

1.01

0.00

1.1

—

(3027944) Amphetamines [Presence] in Urine

109

1.01

0.00

2.1

1.2

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

123

0.97

0.00

1.2

1.4

—

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

128

1.01

0.00

2.1

2.3

—

(3028300) Cannabinoids [Presence] in Urine

113

0.97

0.00

2.1

1.2

—

(3052592) Norovirus Ag [Presence] in Stool

0.92

-0.00

1.2

1.3

—

(3022689) Creatine [Moles/volume] in Urine

0.88

-0.00

1.0

1.5

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

0.86

-0.00

1.4

1.3

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

0.89

-0.00

1.0

1.1

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

0.00

-0.00

0.0

1.0

—

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3028707) Methadone [Presence] in Urine by Screen method

0.88

-0.00

2.6

1.2

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

0.92

-0.00

1.0

1.1

—

(44813793) Dust mix specific IgE antibody measurement

0.91

-0.00

1.3

1.0

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

1.3

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

0.00

-0.00

0.0

6.2

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.2

—

405.08

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.1

—

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

2.2

—

2.60

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

0.94

-0.00

1.0

1.1

—

(3026250) Tacrolimus [Mass/volume] in Blood

1.02

-0.00

39.0

30.6

7.06

7.32

ug/l

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.1

—

225.38

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

0.90

-0.00

1.0

1.2

—

47.90

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

0.96

-0.00

1.9

1.3

82.05

62.81

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

0.00

-0.00

0.0

1.0

—

(3047189) Immunofixation for 24 hour Urine

0.94

-0.00

1.0

1.1

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

0.00

-0.00

0.0

1.5

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

-0.00

0.0

1.0

—

(3030313) Adrenal Ab [Titer] in Serum

0.00

-0.00

0.0

1.1

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: C3_BLADDER – Malignant neoplasm of bladder

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Malignant neoplasm of bladder

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Malignant neoplasm of bladder (C3_BLADDER)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints